Rhabdomyoma: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
 
(220 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{SI}}                                                               
{{Rhabdomyoma}}                                                               
{{CMG}}; {{AE}} {{Simrat}}


{{SK}} Rhabdomyomatous neoplasm; Adult rhabdomyoma; Genital rhabdomyoma; Fetal rhabdomyoma
{{CMG}}; {{AE}} {{Nnasiri}}
 
{{SK}} Rhabdomyomatous neoplasm; Adult rhabdomyoma; Genital rhabdomyoma; Fetal rhabdomyoma; Rhabdomyomatous mesenchymal hamartomas


==Overview==
==Overview==
A rhabdomyoma is a [[benign]] [[tumor]] of striated muscle. Rhabdomyomas develop mostly before the age of one year, almost exclusively in children, and approximately 80 to 90 percent are associated with [[tuberous sclerosis]].<ref name="pmid9424072">{{cite journal| author=Beghetti M, Gow RM, Haney I, Mawson J, Williams WG, Freedom RM| title=Pediatric primary benign cardiac tumors: a 15-year review. | journal=Am Heart J | year= 1997 | volume= 134 | issue= 6 | pages= 1107-14 | pmid=9424072 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9424072  }} </ref><ref name="pmid23151153">{{cite journal| author=Kocabaş A, Ekici F, Cetin Iİ, Emir S, Demir HA, Arı ME et al.| title=Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome. | journal=Pediatr Hematol Oncol | year= 2013 | volume= 30 | issue= 2 | pages= 71-9 | pmid=23151153 | doi=10.3109/08880018.2012.734896 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23151153  }} </ref> The most common primary [[pediatric]] tumor of the heart is cardiac rhabdomyoma.<ref name="pmid10865004">{{cite journal| author=Becker AE| title=Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. | journal=Pediatr Cardiol | year= 2000 | volume= 21 | issue= 4 | pages= 317-23 | pmid=10865004 | doi=10.1007/s002460010071 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10865004  }} </ref><ref name="pmid12031001">{{cite journal| author=Elderkin RA, Radford DJ| title=Primary cardiac tumours in a paediatric population. | journal=J Paediatr Child Health | year= 2002 | volume= 38 | issue= 2 | pages= 173-7 | pmid=12031001 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12031001  }} </ref>
Rhabdomyoma is a [[benign]] [[tumor]] of [[Muscle|striated muscle]]. Rhabdomyomas are rare and can be classified into [[cardiac]] type and extracardiac type. The most common primary benign [[pediatric]] tumor of the heart is [[cardiac]] rhabdomyoma which can be seen mainly in [[fetal]] life and children, second most common primary [[benign]] cardiac tumor in children is [[fibroma]]. Most [[tumors]] regress spontaneously, [[prognosis]] depends on the location of [[tumor]] and size. [[Cardiac]] rhabdomyoma is strongly associated with [[tuberous sclerosis]]. [[Cardiac]] rhabdomyoma is seen almost always in the [[pediatric]] age group and is associated with tuberous sclerosis, [[neurofibromatosis]], and [[sebaceous]] [[adenoma]]<nowiki/>s. Extracardiac rhabdomyoma can be divided into three groups (adult, [[fetal]], and [[genital]] types) with distinct clinical and morphological differences. The [[adult]] type is a slowly growing mass which typically involves the [[head]] and [[neck]]. [[Fetal]] type is seen in the head and neck region. The [[genital]] type is almost always found in the vulvovaginal region of older women. Treatment of adult type rhabdomyoma of head and neck depends upon the severity of [[clinical]] [[symptoms]].


==Classification==
==Classification==
*Rhabdomyoma may be classified into the following subtypes:   
Rhabdomyoma may be classified into the following subtypes:  <ref name="pmid25989364">{{cite journal |vauthors=McKinnon EL, Rand AJ, Selim MA, Fuchs HE, Buckley AF, Cummings TJ |title=Rhabdomyomatous mesenchymal hamartoma presenting as a sacral skin tag in two neonates with spinal dysraphism |journal=J. Cutan. Pathol. |volume=42 |issue=10 |pages=774–8 |date=October 2015 |pmid=25989364 |doi=10.1111/cup.12538 |url=}}</ref><ref name="pmid9424072">{{cite journal| author=Beghetti M, Gow RM, Haney I, Mawson J, Williams WG, Freedom RM| title=Pediatric primary benign cardiac tumors: a 15-year review. | journal=Am Heart J | year= 1997 | volume= 134 | issue= 6 | pages= 1107-14 | pmid=9424072 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9424072  }} </ref><ref name="pmid10865004">{{cite journal| author=Becker AE| title=Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. | journal=Pediatr Cardiol | year= 2000 | volume= 21 | issue= 4 | pages= 317-23 | pmid=10865004 | doi=10.1007/s002460010071 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10865004  }} </ref><ref name="pmid12031001">{{cite journal| author=Elderkin RA, Radford DJ| title=Primary cardiac tumours in a paediatric population. | journal=J Paediatr Child Health | year= 2002 | volume= 38 | issue= 2 | pages= 173-7 | pmid=12031001 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12031001  }} </ref><ref name="pmid23151153">{{cite journal| author=Kocabaş A, Ekici F, Cetin Iİ, Emir S, Demir HA, Arı ME et al.| title=Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome. | journal=Pediatr Hematol Oncol | year= 2013 | volume= 30 | issue= 2 | pages= 71-9 | pmid=23151153 | doi=10.3109/08880018.2012.734896 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23151153  }} </ref><ref name="pmid21992817">{{cite journal |vauthors=Lu DY, Chang S, Cook H, Alizadeh Y, Karam AK, Moatamed NA, Dry SM |title=Genital rhabdomyoma of the urethra in an infant girl |journal=Hum. Pathol. |volume=43 |issue=4 |pages=597–600 |date=April 2012 |pmid=21992817 |doi=10.1016/j.humpath.2011.06.012 |url=}}</ref>
*[[Neoplastic]]
 
=== [[Neoplastic]] ===
Neoplastic rhabdomyomas may be further classified into the following types:
:*[[Adult]]
:*[[Adult]]
:*[[Fetal]]
:*[[Fetal]]
:*[[Genital]]
:*[[Genital]]
*[[Hamartoma]]
 
=== [[Hamartoma|Hamartomataous]] ===
Hamartamatous rhabdomyomas may be further classified into the following types:
:*[[Cardiac rhabdomyoma]]
:*[[Cardiac rhabdomyoma]]
:*Rhabdomyomatous mesenchymal hamartomas of the skin
:*Rhabdomyomatous [[mesenchymal]] [[hamartomas]] of the skin(RMH) which is a rare [[congenital]] malformation involving the [[dermis]] and [[subcutaneous]] tissue, it can present as [[skin tag]] or even [[trigeminal neuralgia]] case reported. <ref name="pmid26037964">{{cite journal |vauthors=White LR, Agrawal V, Sutton L, Balbosa AC |title=Rhabdomyomatous mesenchymal hamartoma of the face causing trigeminal neuralgia |journal=Am J Case Rep |volume=16 |issue= |pages=338–40 |date=June 2015 |pmid=26037964 |pmc=4460909 |doi=10.12659/AJCR.893719 |url=}}</ref>


==Staging==
==Staging==
The staging of rhabdomyomas is based on the grade (G), site (T), and [[metastasis]] (M), as follows:
There have not been sufficient studies for the staging of rhabdomyoma. There is staging based on site, [[tumor]] size and [[metastases]] for [[rhabdomyosarcoma]], which is a [[malignant]] tumor of [[striated muscle]].
*G0 - [[Benign]]
*T0 - Intracapsular
*T1 - Extracapsular, intracompartmental
*M0 - None
{| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" align=center
|valign=top|
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|'''Stage'''}}
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|'''Severity'''}}
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|'''Description'''}}
|-
| style="text-align: center;padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:Benign Stage 1
| style="padding: 5px 5px; background: #F5F5F5;" |
*Latent G0T0M0
| style="padding: 5px 5px; background: #F5F5F5;" |
*Remains static or heals spontaneously
|-
| style="text-align: center;padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:Benign Stage 2
| style="padding: 5px 5px; background: #F5F5F5;" |
*Active G0T0M0
| style="padding: 5px 5px; background: #F5F5F5;" |
*Progressive growth but limited by natural barriers
|-
| style="text-align: center;padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:Benign Stage 3
| style="padding: 5px 5px; background: #F5F5F5;" |
*Aggressive G0T1M0
| style="padding: 5px 5px; background: #F5F5F5;" |
*Progressive growth not limited by natural barriers
|-
|}


==Pathophysiology==
==Pathophysiology==
===Pathogenesis===
===Pathogenesis===
*Cardiac rhabdomyomas tend to grow up to approximately 32 weeks [[gestation]]. After, cells usually lose their ability to divide and undergo [[apoptosis]] via a [[ubiquitin|ubiquitin-mediated]] pathway. The degradation of [[myofilament]]s is expressed by ubiquitin. Apoptosis follows, leading to the eventual regression of the [[hamartoma]]. Complete or partial resolution occurs in the majority of cases, regardless of the initial size of the [[tumor]].
 
==== Cardiac Rhabdomyoma ====
*Cardiac rhabdomyoma is typically seen in cases of tuberous sclerosis and the pathogenesis involves mutations in the TSC1 and TSC2 genes.<ref name="urlEnzinger and Weisss Soft Tissue Tumors - 6th Edition">{{cite web |url=https://www.elsevier.com/books/enzinger-and-weisss-soft-tissue-tumors/goldblum/978-0-323-08834-3 |title=Enzinger and Weiss's Soft Tissue Tumors - 6th Edition |format= |work= |accessdate=}}</ref>
*Mutations in the TSC1 and TSC2 genes affect downstream molecular signalling pathways, primarily the mTOR pathway that leads to disrupted cellular growth, proliferation and motility.<ref name="pmid17990907">{{cite journal |vauthors=Kotulska K, Larysz-Brysz M, Grajkowska W, Jóźwiak J, Włodarski P, Sahin M, Lewin-Kowalik J, Domańska-Pakieła D, Jóźwiak S |title=Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities |journal=Pediatr. Dev. Pathol. |volume=12 |issue=2 |pages=89–95 |date=2009 |pmid=17990907 |doi=10.2350/06-11-0191.1 |url=}}</ref><ref name="pmid24053983">{{cite journal |vauthors=Krueger DA, Northrup H |title=Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference |journal=Pediatr. Neurol. |volume=49 |issue=4 |pages=255–65 |date=October 2013 |pmid=24053983 |doi=10.1016/j.pediatrneurol.2013.08.002 |url=}}</ref>
*Activation of mTOR pathway leads to increased translation and protein production by ribosomal protein S6 kinase beta-1 (p70S6K) and eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1), contributing to the abnormal cell growth and proliferation
*[[Cardiac]] rhabdomyoma is usually diagnosed during the second or [[third trimester]] on [[ultrasound]], rhabdomyoma appears as round, homogeneous, hyperechogenic masses in the [[ventricles]], and they sometimes appear as multiple foci in the [[ventricles]] and septal wall. Differential diagnosis between rhabdomyoma, [[fibroma]] or [[myxoma]] using [[ultrasonography]] for a single cardiac mass remains difficult. <ref name="pmid28868251">{{cite journal |vauthors=Sharma N, Sharma S, Thiek JL, Ahanthem SS, Kalita A, Lynser D |title=Maternal and Fetal Tuberous Sclerosis: Do We Know Enough as an Obstetrician? |journal=J Reprod Infertil |volume=18 |issue=2 pages=257–260 |date=2017 |pmid=28868251 |pmc=5565905 |doi= |url=}}</ref><ref name="pmid28507627">{{cite journal |vauthors=Bejiqi R, Retkoceri R, Bejiqi H |title=Prenatally Diagnosis and Outcome of Fetuses with Cardiac Rhabdomyoma - Single Centre Experience |journal=Open Access Maced J Med Sci |volume=5 |issue=2 |pages=193–196 |date=April 2017 |pmid=28507627 |pmc=5420773 |doi=10.3889/oamjms.2017.040 |url=}}</ref>
*[[Cells (biology)|Cells]] usually lose their ability to divide and undergo [[apoptosis]] via a [[ubiquitin|ubiquitin-mediated]] pathway and regression of the [[hamartoma]] ensues.<ref name="pmid11815866">{{cite journal |vauthors=Wu SS, Collins MH, de Chadarévian JP |title=Study of the regression process in cardiac rhabdomyomas |journal=Pediatr. Dev. Pathol. |volume=5 |issue=1 |pages=29–36 |date=2002 |pmid=11815866 |doi= |url=}}</ref>
*Result can be complete or partial regression of [[hamartoma]] tumor.
 
==== Extracardiac Rhabdomyoma ====
* The pathogenesis of extracardiac rhabdomyoma is largely unknown, however, constitutive activation of the Hedgehog signalling (SHH pathway activation) and association with Gorlin’s syndrome have been implicated as the two key mechanisms leading to development of these soft tissue tumors.<ref name="pmid24517962">{{cite journal |vauthors=Hettmer S, Teot LA, Kozakewich H, Werger AM, Davies KJ, Fletcher CD, Grier HE, Rodriguez-Galindo C, Wagers AJ |title=Myogenic tumors in nevoid Basal cell carcinoma syndrome |journal=J. Pediatr. Hematol. Oncol. |volume=37 |issue=2 |pages=147–9 |date=March 2015 |pmid=24517962 |pmc=4127382 |doi=10.1097/MPH.0000000000000115 |url=}}</ref><ref name="pmid23841004">{{cite journal |vauthors=de Trey LA, Schmid S, Huber GF |title=Multifocal adult rhabdomyoma of the head and neck manifestation in 7 locations and review of the literature |journal=Case Rep Otolaryngol |volume=2013 |issue= |pages=758416 |date=2013 |pmid=23841004 |pmc=3697226 |doi=10.1155/2013/758416 |url=}}</ref>


====Location====
====Location====
*The head and neck area harbors approximately 90% of adult rhabdomyomas.  
*Approximately 90% of adult rhabdomyoma are found in head and neck.<ref name="pmid16419079">{{cite journal |vauthors=Bjørndal Sørensen K, Godballe C, Ostergaard B, Krogdahl A |title=Adult extracardiac rhabdomyoma: light and immunohistochemical studies of two cases in the parapharyngeal space |journal=Head Neck |volume=28 |issue=3 |pages=275–9 |date=March 2006 |pmid=16419079 |doi=10.1002/hed.20358 |url=}}</ref><ref name="pmid24288631">{{cite journal |vauthors=Amelia Souza A, de Araújo VC, Passador Santos F, Ferreira Martinez E, de Menezes Filho JF, Soares de Araujo N, Soares AB |title=Intraoral adult rhabdomyoma: a case report |journal=Case Rep Dent |volume=2013 |issue= |pages=741548 |date=2013 |pmid=24288631 |pmc=3833031 |doi=10.1155/2013/741548 |url=}}</ref>
*Adult rhabdomyoma is localized to the [[oropharynx]], the [[larynx]], and the muscles of the neck.
*[[Adult]] rhabdomyoma is localized to the [[oropharynx]], the [[larynx]], and the muscles of the neck.
*Fetal rhabdomyoma occurs most often in the [[subcutaneous tissue]]s of the head and neck in children.
*[[Fetal]] rhabdomyoma occurs most often in the [[subcutaneous tissue]]s of the [[Head and neck anatomy|head and neck]] in children.
*Genital rhabdomyoma most often involves the vagina or [[vulva]].
*[[Genital]] rhabdomyoma most often involves the [[vagina]] or [[vulva]].
*Cardiac rhabdomyoma usually involves the [[myocardium]] of both [[ventricles]] and the [[interventricular septum]],, but can be located in the [[atria]], the [[epicardial|epicardial surface]], or the cavoatrial junction.
*Location of [[cardiac]] rhabdomyoma determines the clinical presentation, it usually is multi foci and involves the [[myocardium]] of both [[ventricles]] and/or the [[interventricular septum]], but can be found in the [[atrium]] as well as endocardium.


====Immunohistochemistry====
====Immunohistochemistry====
*Cross-striation has been demonstrated by muscle specific [[actin]], [[phosphotungstic acid hematoxylin]] ([[PTAH]]), [[desmin]], and [[myoglobin]].
*Immunohistological cell markers include:
*[[Dystrophin]] is shown to be expressed in the cell membranes.
**[[Muscle]] specific [[actin]], [[phosphotungstic acid hematoxylin]] ([[PTAH]]), [[desmin]], and [[myoglobin]].<ref name="pmid16419079">{{cite journal |vauthors=Bjørndal Sørensen K, Godballe C, Ostergaard B, Krogdahl A |title=Adult extracardiac rhabdomyoma: light and immunohistochemical studies of two cases in the parapharyngeal space |journal=Head Neck |volume=28 |issue=3 |pages=275–9 |date=March 2006 |pmid=16419079 |doi=10.1002/hed.20358 |url=}}</ref>
**[[Dystrophin]] is shown to be expressed in the cell membranes.


===Associated Conditions===
==Associated Conditions==
*Cardiac rhabdomyoma is a hamartomatous proliferation frequently associated with [[sebaceous]] adenomas, [[tuberous sclerosis]] of the brain, and various hamartomatous lesions of the [[kidney]] and other organs.
*[[Cardiac]] rhabdomyoma is associated with a variety of abnormalities such as :<ref name="pmid25328743">{{cite journal |vauthors=Castilla Cabanes E, Lacambra Blasco I |title=Multiple cardiac rhabdomyomas, wolff-Parkinson-white syndrome, and tuberous sclerosis: an infrequent combination |journal=Case Rep Pediatr |volume=2014 |issue= |pages=973040 |date=2014 |pmid=25328743 |pmc=4189844 |doi=10.1155/2014/973040 |url=}}</ref>
**[[Tuberous sclerosis]] (most common associated genetical abnormality)
**Brain lesions
**[[Down syndrome]]
** [[Wolff-Parkinson-White syndrome]] ([[WPW]])
**[[Ebstein anomaly]]
**[[Tetralogy of Fallot]]
**[[Hypoplastic left heart syndrome]]


===Gross Pathology===
==Gross Pathology==
*On gross pathology, round or polypoid mass in the region of the neck are characteristic findings of adult rhabdomyoma.
*On gross [[pathology]], round or [[Polypoidy|polypoid]] mass in the region of the [[neck]] are characteristic findings of adult rhabdomyoma.    
*On gross pathology, characteristic findings of cardiac rhabdomyomas may include:
**Round or lobulated, well-circumscribed masses which can be up to 10 cm in diameter.<ref name="pmid25018846">{{cite journal |vauthors=Kassop D, Donovan MS, Cheezum MK, Nguyen BT, Gambill NB, Blankstein R, Villines TC |title=Cardiac Masses on Cardiac CT: A Review |journal=Curr Cardiovasc Imaging Rep |volume=7 |issue= |pages=9281 |date=2014 |pmid=25018846 |pmc=4090749 |doi=10.1007/s12410-014-9281-1 |url=}}</ref>
**Round or lobulated, grossly well circumscribed masses which range from 1 mm to 10 cm in their greatest dimension
**Isolated or multiple.
**Isolated or multiple
**Solid tan-white [[homogeneous]] consistency, often watery and glistening on their cut surface.
**Solid tan-white [[homogeneous]] consistency, often watery and glistening on their cut surface
**Infrequently, [[calcification]] and [[hemorrhage]].
**Infrequently, [[calcification]] and [[hemorrhage]]  


===Microscopic Pathology===
[[File:Cardiac rhabdomyoma.jpg|thumb|left|Cardiac rhabdomyoma Gross. [https://commons.wikimedia.org/wiki/File:Cardiac_rhabdomyoma.jpg Source: http://peir2.path.uab.edu/pdl/dbra.cgi?uid=default&view_search=1]]]<br style="clear:left" />
*On microscopic histopathological analysis, characteristic findings of adult rhabdomyoma include:
 
**Well-differentiated large cells, which are deeply [[eosinophilic]] polygonal with small, peripherally placed nuclei
==Microscopic Pathology==
**Occasionally, intracellular vacuoles, which resemble striated muscle cells
*On [[microscopic]] histopathological analysis, characteristic findings of adult rhabdomyoma include:
*On microscopic histopathological analysis, characteristic findings of fetal rhabdomyoma include [[spindle]]-shaped cells with indistinct cytoplasm and muscle fibers, which resemble [[striated muscle]] tissue seen in [[intrauterine]] development at 7-12 weeks.
**Polygonal cells with [[eosinophilic]] granular [[cytoplasm]] that is mixed with intracellular vacuolated cells.
*On microscopic histopathological analysis, characteristic findings of genital rhabdomyoma include:
**Rhabdomyomas are very well differentiated similarly to [[striated muscle]] cells which present markers such as [[actin]], [[desmin]], and [[myoglobin]]; [[dystrophin]] on their cell membranes. <ref name="pmid12028157">{{cite journal |vauthors=Rosenberg AS, Kirk J, Morgan MB |title=Rhabdomyomatous mesenchymal hamartoma: an unusual dermal entity with a report of two cases and a review of the literature |journal=J. Cutan. Pathol. |volume=29 |issue=4 |pages=238–43 |date=April 2002 |pmid=12028157 |doi= |url=}}</ref>
**A mixture of [[fibroblast]] cells with clusters of mature cells containing distinct cross-striations
*[[Histopathologic]] findings of [[fetal]] rhabdomyoma include [[spindle]]-shaped cells with vacuolated clear cytoplasm due to loss of [[glycogen]] or granulated ones.
**A matrix containing varying amounts of [[collagen]] and mucoid material
*On [[microscopic]] histopathological analysis, characteristic findings of [[genital]] rhabdomyoma include:
*On microscopic histopathological analysis, characteristic findings of cardiac rhabdomyoma include cells that closely resemble embryonic [[cardiac]] muscle cells.  
**[[Fibroblast]] cells among them mature striated cells.
*On microscopic histopathological analysis, characteristic findings of rhabdomyomatous mesenchymal [[hamartoma]] of the skin include lesions which contain poorly oriented or perpendicular bundles of well-differentiated skeletal muscle with islands of fat, fibrous tissue, and occasionally proliferating nerves.
**A matrix containing varying amounts of [[collagen]] and [[Mucous|mucoid]] material
*On [[microscopic]] histopathological analysis, characteristic findings of [[cardiac]] rhabdomyoma include of classic "spider cells" muscle cells similar to [[Embryon|embryonic]] [[myofibrils]].<ref name="pmid952267">{{cite journal |vauthors=Fenoglio JJ, MCAllister HA, Ferrans VJ |title=Cardiac rhabdomyoma: a clinicopathologic and electron microscopic study |journal=Am. J. Cardiol. |volume=38 |issue=2 |pages=241–51 |date=August 1976 |pmid=952267 |doi= |url=}}</ref>
*On [[microscopic]] histopathological findings of Rhabdomyomatous [[mesenchymal]] [[hamartoma]] (RMH) which is a rare [[congenital]] lesion of the dermis and soft tissues consisting of a disordered and varied collection of mature [[adipose tissue]], [[Skeletal muscles|skeletal muscle]], [[adnexal]] elements, and nerve bundles. Rhabdomyomatous [[mesenchymal]] [[hamartoma]] has different names including [[striated muscle]] hamartoma, [[congenital]] midline [[hamartoma]], and hamartoma of [[cutaneous]] adnexa and mesenchyme. Several published cases report the occurrence of RMH within the setting of other uncommon [[congenital]] abnormalities.<ref name="pmid12028157">{{cite journal |vauthors=Rosenberg AS, Kirk J, Morgan MB |title=Rhabdomyomatous mesenchymal hamartoma: an unusual dermal entity with a report of two cases and a review of the literature |journal=J. Cutan. Pathol. |volume=29 |issue=4 |pages=238–43 |date=April 2002 |pmid=12028157 |doi= |url=}}</ref>
[[File:Fetal intermediate cellular type rhabdomyoma.jpg|250px|thumb|left|fetal rhabdomyoma H&E stain [https:https://en.wikipedia.org/wiki/Rhabdomyoma#/media/File:Fetal_intermediate_cellular_type_rhabdomyoma.JPG source:Jerad M Gardner, MD]]]<br style="clear:left" />


==Causes==
==Causes==
*Adult rhabdomyomas are almost totally matured neoplasms of clonal origin.  
*[[Adult]] rhabdomyomas are matured [[neoplasm]]<nowiki/>s of clonal origin.  
*Cardiac rhabdomyoma may be caused by either sporadic [[mutation]] or in the setting of certain genetic disorders.
*[[Cardiac]] rhabdomyoma may be caused by either sporadic [[mutation]] or in the setting of certain genetic disorders.<ref name="pmid18402818">{{cite journal| author=Burke A, Virmani R| title=Pediatric heart tumors. | journal=Cardiovasc Pathol | year= 2008 | volume= 17 | issue= 4 | pages= 193-8 | pmid=18402818 | doi=10.1016/j.carpath.2007.08.008 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18402818  }} </ref>
*Approximately more than 50% of rhabdomyomas are caused by sporadic mutations.<ref name="pmid18402818">{{cite journal| author=Burke A, Virmani R| title=Pediatric heart tumors. | journal=Cardiovasc Pathol | year= 2008 | volume= 17 | issue= 4 | pages= 193-8 | pmid=18402818 | doi=10.1016/j.carpath.2007.08.008 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18402818  }} </ref> However, in rare cases,  [[Ebstein anomaly]], [[tetralogy of Fallot]], and [[hypoplastic left heart syndrome]] can be associated with cardiac rhabdomyoma.
*The [[genetic]] disorder commonly associated with [[cardiac]] rhabdomyoma is [[tuberous sclerosis]].<ref name="pmid11357016">{{cite journal| author=Vaughan CJ, Veugelers M, Basson CT| title=Tumors and the heart: molecular genetic advances. | journal=Curr Opin Cardiol | year= 2001 | volume= 16 | issue= 3 | pages= 195-200 | pmid=11357016 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11357016  }} </ref> Other genetic disorders associated with cardiac rhabdomyomas include [[basal cell nevus syndrome]] and [[Down syndrome]] in the setting of [[tuberous sclerosis]].<ref name="pmid15360117">{{cite journal| author=Isaacs H| title=Fetal and neonatal cardiac tumors. | journal=Pediatr Cardiol | year= 2004 | volume= 25 | issue= 3 | pages= 252-73 | pmid=15360117 | doi=10.1007/s00246-003-0590-4 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15360117  }} </ref><ref name="pmid10419607">{{cite journal| author=Krapp M, Baschat AA, Gembruch U, Gloeckner K, Schwinger E, Reusche E| title=Tuberous sclerosis with intracardiac rhabdomyoma in a fetus with trisomy 21: case report and review of literature. | journal=Prenat Diagn | year= 1999 | volume= 19 | issue= 7 | pages= 610-3 | pmid=10419607 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10419607  }} </ref>
*The genetic disorder commonly associated with cardiac rhabdomyoma is [[tuberous sclerosis]].<ref name="pmid11357016">{{cite journal| author=Vaughan CJ, Veugelers M, Basson CT| title=Tumors and the heart: molecular genetic advances. | journal=Curr Opin Cardiol | year= 2001 | volume= 16 | issue= 3 | pages= 195-200 | pmid=11357016 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11357016  }} </ref> Other genetic disorders associated with cardiac rhabdomyomas include [[basal cell nevus syndrome]] and [[Down syndrome]] in the setting of tuberous sclerosis.<ref name="pmid15360117">{{cite journal| author=Isaacs H| title=Fetal and neonatal cardiac tumors. | journal=Pediatr Cardiol | year= 2004 | volume= 25 | issue= 3 | pages= 252-73 | pmid=15360117 | doi=10.1007/s00246-003-0590-4 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15360117  }} </ref><ref name="pmid10419607">{{cite journal| author=Krapp M, Baschat AA, Gembruch U, Gloeckner K, Schwinger E, Reusche E| title=Tuberous sclerosis with intracardiac rhabdomyoma in a fetus with trisomy 21: case report and review of literature. | journal=Prenat Diagn | year= 1999 | volume= 19 | issue= 7 | pages= 610-3 | pmid=10419607 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10419607  }} </ref>
*The familial form of [[tuberous sclerosis]] are [[hamartomas]] that can involve the [[kidneys]], [[heart]], [[skin]], [[brain]], and other organs.
*The familial form of tuberous sclerosis is an [[autosomal dominant]] disorder characterized by widespread hamartomas that may involve the [[kidneys]], [[heart]], [[skin]], [[brain]], and other organs. The association of cardiac rhabdomyoma and tuberous sclerosis is important and has been explained by strong clinical association. Molecular evidence of this association has been identified as the ''TSC2'' gene [[missense mutation]].
*[[Cardiac]] rhabdomyoma can be the only presenting sign of [[tuberous sclerosis]] and there are strongly related, in fact, [[tuberous sclerosis]] in a fetus can be detected as cardiac rhabdomyoma on [[ultrasound]].<ref name="pmid28868251">{{cite journal |vauthors=Sharma N, Sharma S, Thiek JL, Ahanthem SS, Kalita A, Lynser D |title=Maternal and Fetal Tuberous Sclerosis: Do We Know Enough as an Obstetrician? |journal=J Reprod Infertil |volume=18 |issue=2 |pages=257–260 |date=2017 |pmid=28868251 |pmc=5565905 |doi= |url=}}</ref>
*Cardiac rhabdomyoma is caused by a mutation in the ''TSC-1'' on chromosome 9q34 that encodes for protein hamartin, and ''TSC-2'' on 16p13 that encodes for [[tuberin]]. These genes are both [[tumor suppressor genes]] that assist in the regulation of growth and differentiation of developing [[cardiomyocytes]].
*[[Molecular]] evidence of this association has been identified as the ''[[TSC2]]'' [[gene]] [[missense mutation]].
*[[Cardiac]] rhabdomyoma is caused by a [[mutation]] in the ''[[TSC1 (gene)|TSC1]]'' on [[chromosome]] 9q34 that encodes for protein [[hamartin]], and ''[[TSC2]]'' on 16p13 that encodes for [[tuberin]]. These [[Gene|genes]] are both [[tumor suppressor genes]] that assist in the regulation of [[growth]] and differentiation of developing [[cardiomyocyte]]<nowiki/>s<ref name="pmid2691673">{{cite journal |vauthors=Goldenberg DL |title=A review of the role of tricyclic medications in the treatment of fibromyalgia syndrome |journal=J Rheumatol Suppl |volume=19 |issue= |pages=137–9 |date=November 1989 |pmid=2691673 |doi= |url=}}</ref>


==Differentiating Rhabdomyoma from Other Diseases==
==Differentiating Rhabdomyoma from Other Diseases==
*Rhabdomyomas must be differentiated from other diseases, such as:
*Rhabdomyomas must be differentiated from other diseases, such as:<ref name="pmid27655257">{{cite journal |vauthors=Nasr E, Ibrahim M, Yacoub M |title=Heart failure in a neonate with multiple cardiac masses |journal=Heart |volume=103 |issue=1 |pages=18 |date=January 2017 |pmid=27655257 |doi=10.1136/heartjnl-2016-310251 |url=}}</ref>
:*[[Fibroma]]
:*[[Rhabdomyosarcoma]]
:*Hibernoma
:*Hibernoma
:*Reticulohistiocytoma
:*Reticulo[[histiocytoma]]
:*[[Tuberous sclerosis]]
:*[[Tuberous sclerosis]]
:*[[Granular cell tumor]]s
:*[[Granular cell tumor]]s
=== Differential Diagnosis of Cardiac Rhabdomyoma ===
Cardiac rhabdomyoma should be differentiated from other cardiac tumors that present as a cardiac mass. The following are the differentials:<ref name="pmid27600455">{{cite journal |vauthors=Mankad R, Herrmann J |title=Cardiac tumors: echo assessment |journal=Echo Res Pract |volume=3 |issue=4 |pages=R65–R77 |date=December 2016 |pmid=27600455 |pmc=5292983 |doi=10.1530/ERP-16-0035 |url=}}</ref><ref name="pmid22283202">{{cite journal |vauthors=Zaragoza-Macias E, Zaragosa-Macias E, Chen MA, Gill EA |title=Real time three-dimensional echocardiography evaluation of intracardiac masses |journal=Echocardiography |volume=29 |issue=2 |pages=207–19 |date=February 2012 |pmid=22283202 |doi=10.1111/j.1540-8175.2011.01627.x |url=}}</ref><ref name="pmid7062746">{{cite journal |vauthors=Larrieu AJ, Jamieson WR, Tyers GF, Burr LH, Munro AI, Miyagishima RT, Gerein AN, Allen P |title=Primary cardiac tumors: experience with 25 cases |journal=J. Thorac. Cardiovasc. Surg. |volume=83 |issue=3 |pages=339–48 |date=March 1982 |pmid=7062746 |doi= |url=}}</ref><ref name="pmid2237900">{{cite journal |vauthors=Molina JE, Edwards JE, Ward HB |title=Primary cardiac tumors: experience at the University of Minnesota |journal=Thorac Cardiovasc Surg |volume=38 Suppl 2 |issue= |pages=183–91 |date=August 1990 |pmid=2237900 |doi=10.1055/s-2007-1014064 |url=}}</ref><ref name="pmid1434856">{{cite journal |vauthors=Tazelaar HD, Locke TJ, McGregor CG |title=Pathology of surgically excised primary cardiac tumors |journal=Mayo Clin. Proc. |volume=67 |issue=10 |pages=957–65 |date=October 1992 |pmid=1434856 |doi= |url=}}</ref><ref name="pmid14728061">{{cite journal |vauthors=Sarjeant JM, Butany J, Cusimano RJ |title=Cancer of the heart: epidemiology and management of primary tumors and metastases |journal=Am J Cardiovasc Drugs |volume=3 |issue=6 |pages=407–21 |date=2003 |pmid=14728061 |doi=10.2165/00129784-200303060-00004 |url=}}</ref><ref name="pmid7382545">{{cite journal |vauthors=St John Sutton MG, Mercier LA, Giuliani ER, Lie JT |title=Atrial myxomas: a review of clinical experience in 40 patients |journal=Mayo Clin. Proc. |volume=55 |issue=6 |pages=371–6 |date=June 1980 |pmid=7382545 |doi= |url=}}</ref><ref name="pmid11388092">{{cite journal |vauthors=Pinede L, Duhaut P, Loire R |title=Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases |journal=Medicine (Baltimore) |volume=80 |issue=3 |pages=159–72 |date=May 2001 |pmid=11388092 |doi= |url=}}</ref><ref name="pmid7477198">{{cite journal |vauthors=Reynen K |title=Cardiac myxomas |journal=N. Engl. J. Med. |volume=333 |issue=24 |pages=1610–7 |date=December 1995 |pmid=7477198 |doi=10.1056/NEJM199512143332407 |url=}}</ref><ref name="pmid24642215">{{cite journal |vauthors=Javed A, Zalawadiya S, Kovach J, Afonso L |title=Aortic valve myxoma at the extreme age: a review of literature |journal=BMJ Case Rep |volume=2014 |issue= |pages= |date=March 2014 |pmid=24642215 |pmc=3962858 |doi=10.1136/bcr-2013-202689 |url=}}</ref><ref name="pmid17698701">{{cite journal |vauthors=Lee VH, Connolly HM, Brown RD |title=Central nervous system manifestations of cardiac myxoma |journal=Arch. Neurol. |volume=64 |issue=8 |pages=1115–20 |date=August 2007 |pmid=17698701 |doi=10.1001/archneur.64.8.1115 |url=}}</ref><ref name="pmid4010501">{{cite journal |vauthors=Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL |title=The complex of myxomas, spotty pigmentation, and endocrine overactivity |journal=Medicine (Baltimore) |volume=64 |issue=4 |pages=270–83 |date=July 1985 |pmid=4010501 |doi= |url=}}</ref><ref name="pmid10028128">{{cite journal |vauthors=McAllister HA, Hall RJ, Cooley DA |title=Tumors of the heart and pericardium |journal=Curr Probl Cardiol |volume=24 |issue=2 |pages=57–116 |date=February 1999 |pmid=10028128 |doi= |url=}}</ref><ref name="pmid9283541">{{cite journal |vauthors=Klarich KW, Enriquez-Sarano M, Gura GM, Edwards WD, Tajik AJ, Seward JB |title=Papillary fibroelastoma: echocardiographic characteristics for diagnosis and pathologic correlation |journal=J. Am. Coll. Cardiol. |volume=30 |issue=3 |pages=784–90 |date=September 1997 |pmid=9283541 |doi= |url=}}</ref><ref name="pmid26046736">{{cite journal |vauthors=Tamin SS, Maleszewski JJ, Scott CG, Khan SK, Edwards WD, Bruce CJ, Oh JK, Pellikka PA, Klarich KW |title=Prognostic and Bioepidemiologic Implications of Papillary Fibroelastomas |journal=J. Am. Coll. Cardiol. |volume=65 |issue=22 |pages=2420–9 |date=June 2015 |pmid=26046736 |doi=10.1016/j.jacc.2015.03.569 |url=}}</ref><ref name="pmid12947356">{{cite journal |vauthors=Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BC, Sacchi TJ |title=Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases |journal=Am. Heart J. |volume=146 |issue=3 |pages=404–10 |date=September 2003 |pmid=12947356 |doi=10.1016/S0002-8703(03)00249-7 |url=}}</ref><ref name="pmid9424072">{{cite journal |vauthors=Beghetti M, Gow RM, Haney I, Mawson J, Williams WG, Freedom RM |title=Pediatric primary benign cardiac tumors: a 15-year review |journal=Am. Heart J. |volume=134 |issue=6 |pages=1107–14 |date=December 1997 |pmid=9424072 |doi= |url=}}</ref><ref name="pmid2239731">{{cite journal |vauthors=Smythe JF, Dyck JD, Smallhorn JF, Freedom RM |title=Natural history of cardiac rhabdomyoma in infancy and childhood |journal=Am. J. Cardiol. |volume=66 |issue=17 |pages=1247–9 |date=November 1990 |pmid=2239731 |doi= |url=}}</ref><ref name="pmid7979700">{{cite journal |vauthors=Jacobs JP, Konstantakos AK, Holland FW, Herskowitz K, Ferrer PL, Perryman RA |title=Surgical treatment for cardiac rhabdomyomas in children |journal=Ann. Thorac. Surg. |volume=58 |issue=5 |pages=1552–5 |date=November 1994 |pmid=7979700 |doi= |url=}}</ref><ref name="pmid18824772">{{cite journal |vauthors=Elbardissi AW, Dearani JA, Daly RC, Mullany CJ, Orszulak TA, Puga FJ, Schaff HV |title=Survival after resection of primary cardiac tumors: a 48-year experience |journal=Circulation |volume=118 |issue=14 Suppl |pages=S7–15 |date=September 2008 |pmid=18824772 |doi=10.1161/CIRCULATIONAHA.107.783126 |url=}}</ref><ref name="pmid8049952">{{cite journal |vauthors=Basu S, Folliguet T, Anselmo M, Greengart A, Sabado M, Cunningham JN, Jacobowitz IJ |title=Lipomatous hypertrophy of the interatrial septum |journal=Cardiovasc Surg |volume=2 |issue=2 |pages=229–31 |date=April 1994 |pmid=8049952 |doi= |url=}}</ref><ref name="pmid18428209">{{cite journal |vauthors=Simpson L, Kumar SK, Okuno SH, Schaff HV, Porrata LF, Buckner JC, Moynihan TJ |title=Malignant primary cardiac tumors: review of a single institution experience |journal=Cancer |volume=112 |issue=11 |pages=2440–6 |date=June 2008 |pmid=18428209 |doi=10.1002/cncr.23459 |url=}}</ref><ref name="pmid10807431">{{cite journal |vauthors=Vander Salm TJ |title=Unusual primary tumors of the heart |journal=Semin. Thorac. Cardiovasc. Surg. |volume=12 |issue=2 |pages=89–100 |date=April 2000 |pmid=10807431 |doi= |url=}}</ref><ref name="pmid1008078">{{cite journal |vauthors=Petersen CD, Robinson WA, Kurnick JE |title=Involvement of the heart and pericardium in the malignant lymphomas |journal=Am. J. Med. Sci. |volume=272 |issue=2 |pages=161–5 |date=1976 |pmid=1008078 |doi= |url=}}</ref><ref name="pmid16595790">{{cite journal |vauthors=Ragland MM, Tak T |title=The role of echocardiography in diagnosing space-occupying lesions of the heart |journal=Clin Med Res |volume=4 |issue=1 |pages=22–32 |date=March 2006 |pmid=16595790 |pmc=1447535 |doi= |url=}}</ref><ref name="pmid20227122">{{cite journal |vauthors=Miguel CE, Bestetti RB |title=Primary cardiac lymphoma |journal=Int. J. Cardiol. |volume=149 |issue=3 |pages=358–63 |date=June 2011 |pmid=20227122 |doi=10.1016/j.ijcard.2010.02.016 |url=}}</ref><ref name="pmid10903697">{{cite journal |vauthors=Grebenc ML, Rosado de Christenson ML, Burke AP, Green CE, Galvin JR |title=Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation |journal=Radiographics |volume=20 |issue=4 |pages=1073–103; quiz 1110–1, 1112 |date=2000 |pmid=10903697 |doi=10.1148/radiographics.20.4.g00jl081073 |url=}}</ref><ref name="pmid9869763">{{cite journal |vauthors=Grinda JM, Couetil JP, Chauvaud S, D'Attellis N, Berrebi A, Fabiani JN, Deloche A, Carpentier A |title=Cardiac valve papillary fibroelastoma: surgical excision for revealed or potential embolization |journal=J. Thorac. Cardiovasc. Surg. |volume=117 |issue=1 |pages=106–10 |date=January 1999 |pmid=9869763 |doi= |url=}}</ref><ref name="pmid8466239">{{cite journal |vauthors=Webb DW, Thomas RD, Osborne JP |title=Cardiac rhabdomyomas and their association with tuberous sclerosis |journal=Arch. Dis. Child. |volume=68 |issue=3 |pages=367–70 |date=March 1993 |pmid=8466239 |pmc=1793857 |doi= |url=}}</ref><ref name="pmid19493870">{{cite journal |vauthors=Yoshitake I, Hata M, Sezai A, Niino T, Unosawa S, Shimura K, Kasamaki Y, Minami K |title=Cardiac angiosarcoma with cardiac tamponade diagnosed as a ruptured aneurysm of the sinus valsalva |journal=Jpn. J. Clin. Oncol. |volume=39 |issue=9 |pages=612–5 |date=September 2009 |pmid=19493870 |doi=10.1093/jjco/hyp044 |url=}}</ref><ref name="pmid20939891">{{cite journal |vauthors=Parissis H, Akbar MT, Young V |title=Primary leiomyosarcoma of the right atrium: a case report and literature update |journal=J Cardiothorac Surg |volume=5 |issue= |pages=80 |date=October 2010 |pmid=20939891 |pmc=2964688 |doi=10.1186/1749-8090-5-80 |url=}}</ref><ref name="pmid15383848">{{cite journal |vauthors=Gulati G, Sharma S, Kothari SS, Juneja R, Saxena A, Talwar KK |title=Comparison of echo and MRI in the imaging evaluation of intracardiac masses |journal=Cardiovasc Intervent Radiol |volume=27 |issue=5 |pages=459–69 |date=2004 |pmid=15383848 |doi=10.1007/s00270-004-0123-4 |url=}}</ref><ref name="pmid20150010">{{cite journal |vauthors=Narin B, Arman A, Arslan D, Simşek M, Narin A |title=Assessment of cardiac masses: magnetic resonance imaging versus transthoracic echocardiography |journal=Anadolu Kardiyol Derg |volume=10 |issue=1 |pages=69–74 |date=February 2010 |pmid=20150010 |doi= |url=}}</ref><ref name="urlacademic.oup.com">{{cite web |url=https://academic.oup.com/ehjcimaging/article/8/6/487/2398147 |title=academic.oup.com |format= |work= |accessdate=}}</ref><ref name="pmid26486106">{{cite journal |vauthors=Ismail I, Al-Khafaji K, Mutyala M, Aggarwal S, Cotter W, Hakim H, Khosla S, Arora R |title=Cardiac lipoma |journal=J Community Hosp Intern Med Perspect |volume=5 |issue=5 |pages=28449 |date=2015 |pmid=26486106 |pmc=4612478 |doi=10.3402/jchimp.v5.28449 |url=}}</ref><ref name="pmid28088193">{{cite journal |vauthors=D'Souza J, Shah R, Abbass A, Burt JR, Goud A, Dahagam C |title=Invasive Cardiac Lipoma: a case report and review of literature |journal=BMC Cardiovasc Disord |volume=17 |issue=1 |pages=28 |date=January 2017 |pmid=28088193 |pmc=5237479 |doi=10.1186/s12872-016-0465-2 |url=}}</ref><ref name="YadavBaquero2014">{{cite journal|last1=Yadav|first1=Pradeep K.|last2=Baquero|first2=Giselle A.|last3=Malysz|first3=Jozef|last4=Kelleman|first4=John|last5=Gilchrist|first5=Ian C.|title=Cardiac Paraganglioma|journal=Circulation: Cardiovascular Interventions|volume=7|issue=6|year=2014|pages=851–856|issn=1941-7640|doi=10.1161/CIRCINTERVENTIONS.114.001856}}</ref><ref name="pmid20069088">{{cite journal |vauthors=Tahir M, Noor SJ, Herle A, Downing S |title=Right atrial paraganglioma: a rare primary cardiac neoplasm as a cause of chest pain |journal=Tex Heart Inst J |volume=36 |issue=6 |pages=594–7 |date=2009 |pmid=20069088 |pmc=2801953 |doi= |url=}}</ref><ref name="pmid89769312">{{cite journal |vauthors=Hamilton BH, Francis IR, Gross BH, Korobkin M, Shapiro B, Shulkin BL, Deeb CM, Orringer MB |title=Intrapericardial paragangliomas (pheochromocytomas): imaging features |journal=AJR Am J Roentgenol |volume=168 |issue=1 |pages=109–13 |date=January 1997 |pmid=8976931 |doi=10.2214/ajr.168.1.8976931 |url=}}</ref><ref name="ShihMcCullough1993">{{cite journal|last1=Shih|first1=Wei-Jen|last2=McCullough|first2=Scott|last3=Smith|first3=Mary|title=Diagnostic imagings for primary cardiac fibrosarcoma|journal=International Journal of Cardiology|volume=39|issue=2|year=1993|pages=157–161|issn=01675273|doi=10.1016/0167-5273(93)90028-F}}</ref><ref name="pmid9832064">{{cite journal |vauthors=Arai T, Kurashima C, Wada S, Chida K, Ohkawa S |title=Histological evidence for cell proliferation activity in cystic tumor (endodermal heterotopia) of the atrioventricular node |journal=Pathol. Int. |volume=48 |issue=11 |pages=917–23 |date=November 1998 |pmid=9832064 |doi= |url=}}</ref><ref name="pmid5897246">{{cite journal |vauthors=Wolf PL, Bing R |title=The smallest tumor which causes sudden death |journal=JAMA |volume=194 |issue=6 |pages=674–5 |date=November 1965 |pmid=5897246 |doi= |url=}}</ref><ref name="pmid2222148">{{cite journal |vauthors=Burke AP, Anderson PG, Virmani R, James TN, Herrera GA, Ceballos R |title=Tumor of the atrioventricular nodal region. A clinical and immunohistochemical study |journal=Arch. Pathol. Lab. Med. |volume=114 |issue=10 |pages=1057–62 |date=October 1990 |pmid=2222148 |doi= |url=}}</ref><ref name="pmid26725181">{{cite journal |vauthors=Burke A, Tavora F |title=The 2015 WHO Classification of Tumors of the Heart and Pericardium |journal=J Thorac Oncol |volume=11 |issue=4 |pages=441–52 |date=April 2016 |pmid=26725181 |doi=10.1016/j.jtho.2015.11.009 |url=}}</ref><ref name="TranStarnes2009">{{cite journal|last1=Tran|first1=Thao T|last2=Starnes|first2=Vaughn|last3=Wang|first3=Xuedong|last4=Getzen|first4=James|last5=Ross|first5=Brian D|title=Cardiovascular magnetics resonance diagnosis of cystic tumor of the atrioventricular node|journal=Journal of Cardiovascular Magnetic Resonance|volume=11|issue=1|year=2009|pages=13|issn=1532-429X|doi=10.1186/1532-429X-11-13}}</ref><ref name="TatliO'Gara2004">{{cite journal|last1=Tatli|first1=Servet|last2=O'Gara|first2=Patrick Thomas|last3=Lambert|first3=Jarvis|last4=Kwong|first4=Raymond|last5=Byrne|first5=John Gerald|last6=Yucel|first6=E. Kent|title=MRI of Atypical Lipomatous Hypertrophy of the Interatrial Septum|journal=American Journal of Roentgenology|volume=182|issue=3|year=2004|pages=598–600|issn=0361-803X|doi=10.2214/ajr.182.3.1820598}}</ref><ref name="SabooKrajewski2012">{{cite journal|last1=Saboo|first1=Sachin S.|last2=Krajewski|first2=Katherine M.|last3=Zukotynski|first3=Katherine|last4=Howard|first4=Stephanie|last5=Jagannathan|first5=Jyothi P.|last6=Hornick|first6=Jason L.|last7=Ramaiya|first7=Nikhil|title=Imaging Features of Primary and Secondary Adult Rhabdomyosarcoma|journal=American Journal of Roentgenology|volume=199|issue=6|year=2012|pages=W694–W703|issn=0361-803X|doi=10.2214/AJR.11.8213}}</ref>
{| class="wikitable"
|+
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Site of Tumor
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Malignant Potential
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Type of Tumor
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Tissue of Origin
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Age of Presentation
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Location
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Morphology
! colspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Signs and Symptoms
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |MRI Findings
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Systemic Manifestations
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Cardiac Manifestations
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Embolic Manifestations
|-
| rowspan="13" |Primary Cardiac Tumor
| rowspan="9" |Primary Benign
|Myxoma
|
* Mesenchymal
|
* Between third to sixth decade of life
|
* Left atrium (75%)
* Right atrium (15-20%)
* Arise from border of fossa ovalis
|
* 1-15 cm in diameter
* Pedunculated
* Polypoid
* Smooth and lobulated
* Villous and pappillary appearance associated with embolization
|
* Constitutional symptoms
* Carney complex:
** Spotty skin pigmentation
** Endocrinal tumors such as sertoli testicular tumors, pituitary adenomas, thyroid tumors
** Schwanomma
* NAME syndrome:
** Nevi
** Atrial myxoma
** Myxoid neurofibroma
** Ephelides
* LAMB syndrome:
** Lentigo (small brown patches on the skin)
** Atrial myxoma
** Blue nevi
|
* Dyspnea
* Mitral regurgitation (LA)
* Right heart failure (RA)
* Cardiomegaly
|
* Pulmonary hypertension and pulmonary emboli (RA)
|
* Oval mobile left atrial lesion
* Heterogenous enhancement
* Attachment to fossa ovalis
|-
|Rhabdomyoma
|
* Striated Muscle
|
* Majority (80%) in infants (<12 months)
* Most common cardiac mass in childhood
* 50-70% of all pediatric tumors
|
* Ventricles
* Interventricular septum
|
* 1-3 cm in size
* Yellow-gray color
* Firm
* Circumscribed lobulated
* Majority multiple if associated with tuberous sclerosis (of those with no association, 50% are single)
|
* Associated with tuberous sclerosis:
** Developmental delay
** Renal tumors (angiomyolipomas'')''
** Phakomas (white retinal spots)
** Hypomelanic macules (ash leaf spots)
** Ungal fibromas
** Facial angiofibromas
** Headache
** Blurred vision
** Arrhythmias
** Benign brain tumors (cortical tubers, subependymal nodules)
|
* Outflow obstruction (both right and left ventricles)
* Arrhythmias (ventricular pre-excitation, Wolff-Parkinson White syndrome)
* Spontaneous regression in young cases (< 4 years); seldom regress in adult cases
|
|
* Multiple masses isointense to muscle tissue on T1 images
* Hyperintense on T2 images
|-
|Fibroma
|
* Fibrous
|
* Children (1/3rd in infants)
|
* Ventricles
* Ventricular septum >Left ventricular free wall > Right ventricle > Atria
* Central calcification
|
* Solitary
|
* Cyanosis
|
* Atypical chest pain
* Heart failure
* Cardiomegaly
* Biventricular hypertrophy
* Atrioventricular nodal block
|
|
* Solitary mass
* Low intensity on T2 weighted image
|-
|Fibroelastoma
|
* Valvular endocardium
|
|
* Valvular endocardium (Adults-Aortic, children-Tricuspid)
* Ventrucular surface of aortic and pulmonary valves and atrial surface of atriventricular valves
|
* < 1 cm in diameter
* Solitary
* Papillary
* Flower-like appearance with multiple attachments to valve
* Short pedicle
*
|
* Asymptomatic
* Association with hypertrophic obstructive cardiomyopathy (HOCM)
|
* Subacute bacterial endocarditis
|
* Pulmonary embolism
|
* T1 and T2 weighted images show uniform intermediate signal intensity similar to myocardium
* Homogeneous late gadolinium contrast enhancement
|-
|Hemangioma
|
* Vascular
|
* < 1 year to 70 years
* < 2 % of primary cardiac tumors
|
* Right Ventricle
* Left ventricle
* Right atrium
* Small percentage in interatrial septum and left atrium
|
* Polypoid
* Encapsulated
|
* Cyanosis
* Kasabach-Merritt syndrome (giant hemangiomas):
** Thrombosis
** Thrombocytopenia
** Coagulopathy
|
* Pericardial effusions
* CHF
* Arrhythmias
|
* Pulmonary embolism
* Ischemic stroke
|
* Intermediate density on T1 images
* Hypointense on T2 images
* Multicystic enhancing lesion
* Involvement of epicardium or pericardium
|-
|Lipoma
|
* Adipose
|
* Between fourth to sixth decade of life
|
* Left ventricle (most commonly subendocardium)
* Right atrium
|
* Sessile and small (specially subendocardial that protrude into cardiac chambers)
* Broad pedicle
* Growth into pericardial space
|
* Asymptomatic
|
* Dyspnea
* Local compression (subepicardial)
* Arrhythmia
|
* Ischemic stroke
|
* Epicardial on intramural lesion
* High intensity on T1 weighted image
* Drop out on fat saturation images
|-
|Paraganglioma
|
* Nervous (chromaffin cells of the sympathetic ganglia)
|
* Average age of presentation is 11-13 years
*
|
* Left atrium (under the aorta and the pulmonary artery)
* Interatrial septum
* Left ventricle
* Right ventricular outflow tract
|
* 3-8 cm
* Well-defined
* Broad base
* Encapsulated
* Heterogeneous
* Hypervascular
|
* Majority asymptomatic
* May present with symptoms of catecholamine excess:
** Tachycardia
** Hypertension
** Palipitations
** Fever
** Diaphoresis
* Positive for chromogranin and synaptophysin
* Association with succinate dehydrogenase (SDH) mutation
|
* Dyspnea
* Valvular obstruction (murmurs)
* Acute coronary syndrome (anginal pain)
|
* Enascement of coronary arteries by tumor
|
* Well defined lesion arising from atrial walls or septum
* Bright on T2 weighted imaging
|-
|Atrioventricular Node Tumor
|
* Endodermal
|
* Average age of diagnosis is 38 years
* Female to male ratio 3:1
|
* Triangle of Koch in the AV nodal region of the atrial septum
|
* 2 mm to 2 cm
* Multiple
* Cystic
* Thickening of the atrial septum
|
* Most common cardiac tumor leading to sudden death
* Emery-Dreifuss muscular dystrophy
* Midline developmental defects along the central vertical body axis:
** Thyroglossal duct cysts
** Cysts in the ovaries, breasts
** Ventricular septal defect
** Encephalocele
* Positive for:
** Cytokeratin CAM5.2
** Cytokeratin AE1/AE3
** Cytokeratin 34βE12
** Cytokeratin 5/6 (CK5/6)
** Cytokeratin 7 (CK7)
** Epithelial membrane antigen (EMA)
** Carcinoembryonic antigen (CEA)
** Carbohydrate antigen (CA)19.9, p63, bcl2, galectin 3
|
* Palpitations
* Dyspnea
* Chest pain
* Diziness
* Syncope
* Complete heart block
* Partial AV block
* Paroxysmal atrial arrhythmia
* Spontaneous intermittent pre-excitation
|
* Myocardial infarction
* Ischemic stroke
|
* Hypointense cardiac mass on standard imaging
* Hyperintensity on late gadolinium enhancement (LGE) images with heterogeneous contrast enhancement
|-
|Lipomatous hypertrophy of the interatrial septum
|
* Adipose
|
* > 60 years
|
* Limbus of the fossa ovalis (sparing fossa ovalis membrane)
|
* > 2 cm
* Interatrial septum maybe upto 7 cm in thickness
|
* Mostly asymotmatic
* May present with obstructive symptoms such as syncope in rare cases of extension into superior vena cava
* Associated with:
** Increased age
** Obesity
** Arrhythmias
|
* Palpitations
* Dyspnea
* Fatigue
|<nowiki>-</nowiki>
|
* Diffuse or nodular thickening of atrial walls
* Hyperintense to normal myocardium
* Hypointense to pericardial and posterior mediastinal fat
|-
| rowspan="4" |Primary Malignant
|Fibrosarcoma
|
* Fibrous
|
|
* Left sided (atrial mostly)
|
* Sessile or pedunculated protruding masses in ventricular cavities
* Soft
* Lobulated
* Gelatinous
|
* Fever
* Fatigue
* Malaise
* Weight loss
* Cytoplasmatic positivity for a-SMA
|
* CHF
* Pericardial infiltration (effusions)
|
* Pulmonary embolism
* Ischemic stroke
* Metastasis
|
* Heterogenous or isointense to myocardium on T1 weighted images
|-
|Angiosarcoma
|
* Vascular
|
* Third to fifth decade of life
|
* Right atrium
|
* Broad-based
* Internal hemmorrhage
|
* Fever
* Fatigue
* Weight loss
* Congestion
* Superior vena cava syndrome
* Embolic stroke
* Endothelial marker D2-40
|
* Dyspnea
* CHF
* Pericardial effusions
* Cardiac tamponade
|
* Pulmonary embolism
* Ischemic stroke
* Metastasis
|
* Arterial phase enhancement
|-
|Rhabdomyosarcoma
|
* Mesenchymal
|
* Most common primary sarcoma of children
* Average age of presentation is 20 years
|
* Left sided (atrial mostly)
|
* Multiple
* Three types:
** Embryonic
** Pleomorphic
** Alveolar
|
* Fever
* Fatigue
* Weight loss
* Metastasize to lung and lymph nodes
|
* CHF
* Arrhythmias
|
* Pulmonary embolism
* Ischemic stroke
* Metastasis
|
* Intermediate-to-hypointensity compared with muscle on T1 images
* Hyperintense on T2-weighted imaging with heterogeneous contrast enhancement
|-
|Lymphoma
|
* Lymphoid
|
* First to ninth decade of life
* Males > females
|
* Right sided mostly
|
* Majority solitary (1/3rd multiple)
|
* Associations:
** Chronic immunosupression
** Epstein Barr virus
** HIV
** Diffuse large B cell lymphoma
|
* May involve epicardium and pericardium
|
* Pulmonary embolism
* Ischemic stroke
* Metastasis
|
|-
|Secondary CardiacTumor
|Metastastatic Malignant
|Metastasis
|
* Skin (Melanoma)
* Lung carcinoma
* Lymph (leukemia and lymphoma)
* Breast carcinoma
* Smooth muscle (Esophageal carcinoma)
|
* Any age
|
* Tumors metastasizing via hematogenous route present as multiple intramyocardial masses:
** Melanoma
** Leukemia
** Sarcoma
* Tumors metastasizing via venous system as right sided mass:
** Renal cell carcinoma
** Hepatocellular carcinoma
* Lung tumor metastasizes to left atrium
|
* Multiple
*
|
* Fever
* Fatigue
* Weight loss
* Dysphagia
* Lymphadenopathy
* Night sweats
|
* Pericardial effusions
* Dyspnea
* Arrhytmia
* Outflow obstruction
|
* Pulmonary embolism
* Ischemic stroke
* Metastasis
|
|}


==Epidemiology and Demographics==
==Epidemiology and Demographics==
*Cardiac rhabdomyomas are usually detected during the first year of life or before birth. Cardiac rhabdomyomas account for over 60% of all primary cardiac tumors.
*[[Cardiac]] rhabdomyomas are usually detected during the first year of life or before birth and accounts for majority of all primary cardiac tumors.<ref name="pmid15360117">{{cite journal| author=Isaacs H| title=Fetal and neonatal cardiac tumors. | journal=Pediatr Cardiol | year= 2004 | volume= 25 | issue= 3 | pages= 252-73 | pmid=15360117 | doi=10.1007/s00246-003-0590-4 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15360117  }} </ref><ref name="pmid15942804">{{cite journal| author=Delides A, Petrides N, Banis K| title=Multifocal adult rhabdomyoma of the head and neck: a case report and literature review. | journal=Eur Arch Otorhinolaryngol | year= 2005 | volume= 262 | issue= 6 | pages= 504-6 | pmid=15942804 | doi=10.1007/s00405-004-0840-y | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15942804  }} </ref><ref name="pmid27147810">{{cite journal |vauthors=Ramadani N, Kreshnike KD, Muçaj S, Kabashi S, Hoxhaj A, Jerliu N, Bejiçi R |title=MRI Verification of a Case of Huge Infantile Rhabdomyoma |journal=Acta Inform Med |volume=24 |issue=2 |pages=146–8 |date=April 2016 |pmid=27147810 |pmc=4851540 |doi=10.5455/aim.2016.24.146-148 |url=}}</ref>
*Worldwide, rhabdomyoma is rare.
*Worldwide, rhabdomyoma is rare.
*Approximately 50% of patients with [[tuberous sclerosis]] develop a cardiac rhabdomyoma. Similarly, approximately 51-86% of children diagnosed with cardiac rhabdomyomas demonstrate radiologic or clinical evidence of tuberous sclerosis or have a positive family history. Rhabdomyoma is extremely rare in the United States. Rhabdomyoma has a relative incidence of 5.8%. The incidence of cardiac rhabdomyoma is 0.002-0.25% at autopsy, 0.02-0.08% in live-born infants, and 0.12% in prenatal reviews.<ref name="pmid15360117">{{cite journal| author=Isaacs H| title=Fetal and neonatal cardiac tumors. | journal=Pediatr Cardiol | year= 2004 | volume= 25 | issue= 3 | pages= 252-73 | pmid=15360117 | doi=10.1007/s00246-003-0590-4 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15360117  }} </ref><ref name="pmid15942804">{{cite journal| author=Delides A, Petrides N, Banis K| title=Multifocal adult rhabdomyoma of the head and neck: a case report and literature review. | journal=Eur Arch Otorhinolaryngol | year= 2005 | volume= 262 | issue= 6 | pages= 504-6 | pmid=15942804 | doi=10.1007/s00405-004-0840-y | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15942804  }} </ref>
*Most of patients with [[tuberous sclerosis]] develop a cardiac rhabdomyoma. Similarly, children diagnosed with [[cardiac]] rhabdomyomas demonstrate radiologic or clinical findings of [[Tuberous sclerosis|tuberous]] sclerosis or have a positive family history. Rhabdomyoma is extremely rare in the United States. Rhabdomyoma has a relative [[Incidence (epidemiology)|incidence]] of 5.8%.  


===Age===
===Age===
*Adult rhabdomyoma is more commonly observed among patients aged greater than 40 years old.
*Adult rhabdomyoma is more commonly observed among patients aged greater than 40 years old.<ref name="pmid28507627">{{cite journal |vauthors=Bejiqi R, Retkoceri R, Bejiqi H |title=Prenatally Diagnosis and Outcome of Fetuses with Cardiac Rhabdomyoma - Single Centre Experience |journal=Open Access Maced J Med Sci |volume=5 |issue=2 |pages=193–196 |date=April 2017 |pmid=28507627 |pmc=5420773 |doi=10.3889/oamjms.2017.040 |url=}}</ref>
*Fetal rhabdomyoma is more commonly observed among patients aged between birth and 3 years.
*[[Fetal]] rhabdomyoma is more commonly observed among patients aged between birth and 3 years.
*Cardiac rhabdomyoma is more commonly observed among patients in the [[pediatric]] age group.
*[[Cardiac]] rhabdomyoma is more commonly observed among patients in the [[pediatric]] age group.
*Genital rhabdomyoma is more commonly observed among patients in the young and middle-aged women.
*[[Genital]] rhabdomyoma is more commonly observed among patients in the young and middle-aged women.
*[[Rhabdomyomatous mesenchymal hamartomas]] of the skin is more commonly observed among [[newborns]] and [[infant]]s.
*Rhabdomyomatous [[mesenchymal]] hamartomas of the [[skin]] is more commonly observed among [[newborns]] and [[infant]]s.<ref name="pmid25989364">{{cite journal |vauthors=McKinnon EL, Rand AJ, Selim MA, Fuchs HE, Buckley AF, Cummings TJ |title=Rhabdomyomatous mesenchymal hamartoma presenting as a sacral skin tag in two neonates with spinal dysraphism |journal=J. Cutan. Pathol. |volume=42 |issue=10 |pages=774–8 |date=October 2015 |pmid=25989364 |doi=10.1111/cup.12538 |url=}}</ref>


===Gender===
===Gender===
*Cardiac rhabdomyoma affects men and women equally.
*[[Cardiac]] rhabdomyoma affects men and women equally.<ref name="pmid23841004">{{cite journal |vauthors=de Trey LA, Schmid S, Huber GF |title=Multifocal adult rhabdomyoma of the head and neck manifestation in 7 locations and review of the literature |journal=Case Rep Otolaryngol |volume=2013 |issue= |pages=758416 |date=2013 |pmid=23841004 |pmc=3697226 |doi=10.1155/2013/758416 |url=}}</ref><ref name="pmid15769282">{{cite journal |vauthors=Takeyama J, Hayashi T, Sanada T, Shimanuki Y, Saito M, Shirane R |title=Rhabdomyomatous mesenchymal hamartoma associated with nasofrontal meningocele and dermoid cyst |journal=J. Cutan. Pathol. |volume=32 |issue=4 |pages=310–3 |date=April 2005 |pmid=15769282 |doi=10.1111/j.0303-6987.2005.00312.x |url=}}</ref>
*Rhabdomyomatous mesenchymal hamartoma of skin is observed in male and female newborns and infants equally.
*Rhabdomyomatous [[mesenchymal]] [[hamartoma]] of skin is extremely rare in both genders.  
*Males are more commonly affected with adult rhabdomyoma than females.
*Males are more commonly affected with adult rhabdomyoma than females.
*Males are more commonly affected with fetal rhabdomyoma than females.
*Males are more commonly affected with [[fetal]] rhabdomyoma than females.
*Females are more commonly affected with genital rhabdomyoma than males.
*Females are more commonly affected with [[genital]] rhabdomyoma than males.


===Race===
===Race===
Line 133: Line 605:
==Natural History, Complications and Prognosis==
==Natural History, Complications and Prognosis==
===Natural History===
===Natural History===
*The majority of rhabdomyomas regress spontaneously, and resection is usually not required unless a child is symptomatic.<ref name="pmid10865004">{{cite journal| author=Becker AE| title=Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. | journal=Pediatr Cardiol | year= 2000 | volume= 21 | issue= 4 | pages= 317-23 | pmid=10865004 | doi=10.1007/s002460010071 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10865004  }} </ref><ref name="pmid2239731">{{cite journal| author=Smythe JF, Dyck JD, Smallhorn JF, Freedom RM| title=Natural history of cardiac rhabdomyoma in infancy and childhood. | journal=Am J Cardiol | year= 1990 | volume= 66 | issue= 17 | pages= 1247-9 | pmid=2239731 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2239731  }} </ref>
*The majority of cases regress spontaneously(partial or complete),however there are reported cases which [[surgical]] interventions were necessary,especially if tumor causes [[cardiac]] symptoms such as [[arrhythmia]] or [[obstruction]]. <ref name="pmid29742370">{{cite journal |vauthors=Barnes BT, Procaccini D, Crino J, Blakemore K, Sekar P, Sagaser KG, Jelin AC, Gaur L |title=Maternal Sirolimus Therapy for Fetal Cardiac Rhabdomyomas |journal=N. Engl. J. Med. |volume=378 |issue=19 |pages=1844–1845 |date=May 2018 |pmid=29742370 |pmc=6201692 |doi=10.1056/NEJMc1800352 |url=}}</ref><ref name="pmid10865004">{{cite journal| author=Becker AE| title=Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. | journal=Pediatr Cardiol | year= 2000 | volume= 21 | issue= 4 | pages= 317-23 | pmid=10865004 | doi=10.1007/s002460010071 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10865004  }} </ref><ref name="pmid2239731">{{cite journal| author=Smythe JF, Dyck JD, Smallhorn JF, Freedom RM| title=Natural history of cardiac rhabdomyoma in infancy and childhood. | journal=Am J Cardiol | year= 1990 | volume= 66 | issue= 17 | pages= 1247-9 | pmid=2239731 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2239731  }} </ref>
**Early clinical features include [[heart failure]], [[cardiac murmur]], and [[arrhythmia]].
**Early clinical features include [[heart failure]], [[cardiac murmur]], and [[arrhythmia]].
*If left untreated, cardiac rhabdomyomas generally follows a complete or partial regression with consequent resolution of symptoms. The majority of rhabdomyomas regress spontaneously, and surgical resection is usually not required unless a child is symptomatic.
**Tumors larger in diameter are more likely to cause [[arrhythmia]]s or [[hemodynamic]] instability, which are associated with an increased risk of death.
**If left untreated, tumors larger than 20 mm in diameter are more likely to cause [[arrhythmia]]s or [[hemodynamic]] disturbances, which are associated with an increased risk of death.  
**The majority of patients with [[cardiac]] rhabdomyoma remain asymptomatic; however, some affected patients become symptomatic in the [[perinatal period]].
**The majority of patients with cardiac rhabdomyoma remain asymptomatic; however, some affected patients become symptomatic in the [[perinatal period]].


===Complications===
===Complications===
*Common complications of cardiac rhabdomyoma include development of [[cardiac arrhythmias]], [[ventricular outflow tract]] obstruction, valvular compromise, and disruption of intracardiac blood flow leading to [[congestive heart failure]] and [[hydrops]].
*Common complications of [[cardiac]] rhabdomyoma include development of [[cardiac arrhythmias]], [[ventricular outflow tract]] obstruction, and [[congestive heart failure]].<ref name="pmid25424575">{{cite journal |vauthors=Hinton RB, Prakash A, Romp RL, Krueger DA, Knilans TK |title=Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group |journal=J Am Heart Assoc |volume=3 |issue=6 |pages=e001493 |date=November 2014 |pmid=25424575 |pmc=4338742 |doi=10.1161/JAHA.114.001493 |url=}}</ref>


===Prognosis===
===Prognosis===
*Generally, prognosis is generally good depending on the part of the body involved; the survival rate of patients with rhabdomyoma is approximately 81% to 92%. Rhabdomyomas that alter valve function and lead to [[regurgitation (circulation)|regurgitation} or that obstruct the inflow or [[ventricular outflow tract]]s carry a poor prognosis. The long-term prognosis of cardiac rhabdomyoma is affected by the neurologic manifestations associated with [[tuberous sclerosis]].
*prognosis is generally good; the [[survival rate]] of patients with benign rhabdomyoma is excellent, depending on location of tumor, prognosis may change.<ref name="pmid25870340">{{cite journal |vauthors=Linnemeier L, Benneyworth BD, Turrentine M, Rodefeld M, Brown J |title=Pediatric cardiac tumors: a 45-year, single-institution review |journal=World J Pediatr Congenit Heart Surg |volume=6 |issue=2 |pages=215–9 |date=April 2015 |pmid=25870340 |doi=10.1177/2150135114563938 |url=}}</ref>
*The prognosis of patients with rhabdomyomas is chiefly determined by the size, number and location of the lesions as well as the presence or absence of associated anomalies.
*Rhabdomyomas on [[mitral]] or [[Tricuspid valve|tricuspid]] valves can lead to regurgitation or obstruction of outflow tract thus poor prognosis.<ref name="pmid26891966">{{cite journal |vauthors=Wang Y, Wang X, Xiao Y |title=Surgical treatment of primary cardiac valve tumor: early and late results in eight patients |journal=J Cardiothorac Surg |volume=11 |issue= |pages=31 |date=February 2016 |pmid=26891966 |pmc=4759914 |doi=10.1186/s13019-016-0406-2 |url=}}</ref>
**The morbidity of rhabdomyoma depends on the type of lesion and its location.
*The long-term prognosis of [[cardiac]] rhabdomyoma is affected by the [[neurologic]] manifestations associated with [[tuberous sclerosis]].<ref name="pmid28811058">{{cite journal |vauthors=Chung CWT, Lawson JA, Sarkozy V, Riney K, Wargon O, Shand AW, Cooper S, King H, Kennedy SE, Mowat D |title=Early Detection of Tuberous Sclerosis Complex: An Opportunity for Improved Neurodevelopmental Outcome |journal=Pediatr. Neurol. |volume=76 |issue= |pages=20–26 |date=November 2017 |pmid=28811058 |doi=10.1016/j.pediatrneurol.2017.05.014 |url=}}</ref>
***Patients with cardiac rhabdomyomas have the highest risk.
*The prognosis of patients with rhabdomyomas depends mainly on the size, location, number of the lesions, associated anomalies such as [[tuberous sclerosis]].
*[[Metastases]] have not been associated with rhabdomyoma.
*[[Metastases]] have not been associated with rhabdomyoma.


== Diagnosis ==
== Diagnosis ==
=== Symptoms ===
=== Symptoms ===
*Symptoms of adult rhabdomyoma may include:
*Symptoms of adult rhabdomyoma may include:<ref name="pmid29318074">{{cite journal |vauthors=Altissimi G, Ralli M, Sementilli G, Fiorentino F, Ciofalo A, Greco A, de Vincentiis M, Corsi A, Cianfrone G |title=Adult-Type Rhabdomyoma of the Larynx: Clinicopathologic Study of an Uncommon Tumor in a Rare Location |journal=Case Rep Otolaryngol |volume=2017 |issue= |pages=7186768 |date=2017 |pmid=29318074 |pmc=5727691 |doi=10.1155/2017/7186768 |url=}}</ref>
:*[[Hoarseness]]
:*[[Hoarseness]]
:*[[Difficulty breathing]]
:*[[Difficulty breathing]]
:*[[Difficulty swallowing]]
:*[[Difficulty swallowing]]([[dysphagia]])
:*[[laryngeal]] mass
:*In a very rare occassion can present with symptoms of [[hyperparathyroidism]] if it involves parathyroid gland. <ref name="pmid30537102">{{cite journal |vauthors=Lee JP, Blake Sullivan C, Bayon R, Shearer AE, Robinson RA |title=Adult type rhabdomyoma presenting as a parathyroid adenoma |journal=Head Neck |volume= |issue= |pages= |date=December 2018 |pmid=30537102 |doi=10.1002/hed.25419 |url=}}</ref>
*Symptoms of genital rhabdomyoma may include the following:
*Symptoms of genital rhabdomyoma may include the following:
:*[[Dyspareunia|Painful sexual intercourse due to medical or psychological causes]]
:*[[Dyspareunia|Painful sexual intercourse due to medical or psychological causes]]
*Symptoms of cardiac rhabdomyoma may include the following:
*Symptoms of [[cardiac]] rhabdomyoma may include the following:
:*[[Shortness of breath]]
:*[[Shortness of breath]]
**In cardiac rhabdomyoma, symptoms if present, may be caused by obstruction of blood flow through the heart or consist of rhythm disturbances, such as [[heart block]] and [[ventricular tachycardia]].<ref name="pmid8863873">{{cite journal| author=Bosi G, Lintermans JP, Pellegrino PA, Svaluto-Moreolo G, Vliers A| title=The natural history of cardiac rhabdomyoma with and without tuberous sclerosis. | journal=Acta Paediatr | year= 1996 | volume= 85 | issue= 8 | pages= 928-31 | pmid=8863873 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8863873  }} </ref><ref name="pmid7979700">{{cite journal| author=Jacobs JP, Konstantakos AK, Holland FW, Herskowitz K, Ferrer PL, Perryman RA| title=Surgical treatment for cardiac rhabdomyomas in children. | journal=Ann Thorac Surg | year= 1994 | volume= 58 | issue= 5 | pages= 1552-5 | pmid=7979700 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7979700  }} </ref>
*In [[cardiac]] rhabdomyoma, symptoms if present, may be caused by obstruction of [[blood flow]] through the [[heart]] or consist of rhythm disturbances, such as [[heart block]] and [[ventricular tachycardia]].<ref name="pmid8863873">{{cite journal| author=Bosi G, Lintermans JP, Pellegrino PA, Svaluto-Moreolo G, Vliers A| title=The natural history of cardiac rhabdomyoma with and without tuberous sclerosis. | journal=Acta Paediatr | year= 1996 | volume= 85 | issue= 8 | pages= 928-31 | pmid=8863873 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8863873  }} </ref><ref name="pmid7979700">{{cite journal| author=Jacobs JP, Konstantakos AK, Holland FW, Herskowitz K, Ferrer PL, Perryman RA| title=Surgical treatment for cardiac rhabdomyomas in children. | journal=Ann Thorac Surg | year= 1994 | volume= 58 | issue= 5 | pages= 1552-5 | pmid=7979700 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7979700  }} </ref>


=== Physical Examination ===
=== Physical Examination ===
*Physical examination may be remarkable for:
*Physical examination may be remarkable for:
*The presence of a round or polypoid mass in the region of the neck in adult rhabdomyoma
*The presence of a round or polypoid mass in the region of the neck in adult rhabdomyoma
*Subcutaneous masses in the head and neck regions in fetal rhabdomyoma
*[[Subcutaneous]] masses in the head and neck regions in fetal rhabdomyoma
*Vaginal masses in genital rhabdomyoma
*[[Vaginal]] masses in genital rhabdomyoma
*Cardiac rhabdomyomas may present with heart murmurs; if tuberous sclerosis is associated, the patient may display [[cerebral palsy]]–type signs. Renal functions may be altered.
*Cardiac rhabdomyoma may present with [[Mitral regurgitation|mitral]] or [[tricuspid regurgitation]] murmur.<ref name="pmid17377866">{{cite journal |vauthors=Ono M, Boethig D, Akin E, Goerler H, Breymann T |title=Coexistent cardiac rhabdomyoma with mitral valve anomaly in patients with tuberous sclerosis: a case report |journal=Thorac Cardiovasc Surg |volume=55 |issue=2 |pages=120–1 |date=March 2007 |pmid=17377866 |doi=10.1055/s-2006-924243 |url=}}</ref
&lt;nowiki&gt;&lt;nowiki&gt;*&lt;/nowiki&gt;&#x3C;/nowiki&#x3E;It can present with <nowiki>[[seizures]]</nowiki> or <nowiki>[[cerebral palsy]]</nowiki> if <nowiki>[[tuberous sclerosis]]</nowiki> is involved.<nowiki><ref name="pmid21173003"></nowiki>{{cite journal |vauthors=Staley BA, Vail EA, Thiele EA |title=Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs |journal=Pediatrics |volume=127 |issue=1 |pages=e117–25 |date=January 2011 |pmid=21173003 |pmc=3010088 |doi=10.1542/peds.2010-0192 |url=}}</ref>


=== Laboratory Findings ===
=== Laboratory Findings ===
Line 177: Line 651:


===Imaging Findings===
===Imaging Findings===
*MRI is the imaging modality of choice for rhabdomyoma. Chest CT scan may be helpful in the diagnosis of cardiac rhabdomyoma.
*[[MRI]] is the imaging modality of choice for rhabdomyoma. Chest [[CT scan]] may be helpful in the diagnosis of cardiac rhabdomyoma.
*On ultrasound, rhabdomyoma is characterized by one or more solid hyper echoic mass(es) located in relation to the myocardium. The small lesions can mimic diffuse myocardial thickening.  
*On [[ultrasound]], rhabdomyoma is identified by single or multi foci hyper echoic mass(es) located adjacent to the [[myocardium]].<ref name="pmid27600455">{{cite journal |vauthors=Mankad R, Herrmann J |title=Cardiac tumors: echo assessment |journal=Echo Res Pract |volume=3 |issue=4 |pages=R65–R77 |date=December 2016 |pmid=27600455 |pmc=5292983 |doi=10.1530/ERP-16-0035 |url=}}</ref>
*Radiographs of the chest and affected areas of the body may be helpful in the diagnosis of rhabdomyomas.<ref name="radio"> Germ cell tumors. Radiopedia(2015) http://radiopaedia.org/articles/cardiac-rhabdomyoma Accessed on January 25, 2016</ref>
*X-Rays of the chest and affected areas of the body may be helpful in the diagnosis of rhabdomyomas.
[[File:Fetal-cardiac-rhabdomyoma-1.jpg|250px|thumb|left|fetal cardiac rhabdomyoma [https://radiopaedia.org/articles/cardiac-rhabdomyoma source:Case courtesy of Dr Effendi Mansoor, <a href="https://radiopaedia.org/">Radiopaedia.org</a>. From the case <a href="https://radiopaedia.org/cases/17302">rID: 17302</a>]]]
<br style="clear:left" />
 
=== Other Diagnostic Studies ===
=== Other Diagnostic Studies ===
*Rhabdomyoma may also be diagnosed using [[biopsy]].
*Rhabdomyoma may also be diagnosed using [[biopsy]] since overlap in morphologic features between [[rhabdomyosarcoma]] (RMS) vs. rhabdomyoma makes differential diagnosis difficult.<ref name="pmid30120321">{{cite journal |vauthors=Zhang N, Zeng Z, Li S, Wang F, Huang P |title=High expression of EZH2 as a marker for the differential diagnosis of malignant and benign myogenic tumors |journal=Sci Rep |volume=8 |issue=1 |pages=12331 |date=August 2018 |pmid=30120321 |pmc=6098067 |doi=10.1038/s41598-018-30648-7 |url=}}</ref>
**Any masses, including those found in the head and neck of patients with adult rhabdomyoma, should be biopsied to establish a diagnosis.
*Any masses, including those found in the head and neck of patients with adult rhabdomyoma, should be biopsied to establish a diagnosis.


== Treatment ==
== Treatment ==
=== Medical Therapy ===
=== Medical Therapy ===
*There is no treatment for rhabdomyoma; the mainstay of therapy is supportive care. The majority of patients can be managed conservatively. Conservative management includes frequent monitoring of patients with [[echocardiography]] and [[electrocardiography]].  
*Treatment for rhabdomyoma is supportive care.<ref name="pmid21464184">{{cite journal| author=Tiberio D, Franz DN, Phillips JR| title=Regression of a cardiac rhabdomyoma in a patient receiving everolimus. | journal=Pediatrics | year= 2011 | volume= 127 | issue= 5 | pages= e1335-7 | pmid=21464184 | doi=10.1542/peds.2010-2910 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21464184  }} </ref><ref name="pmid26199144">{{cite journal| author=Wagner R, Riede FT, Seki H, Hornemann F, Syrbe S, Daehnert I et al.| title=Oral Everolimus for Treatment of a Giant Left Ventricular Rhabdomyoma in a Neonate-Rapid Tumor Regression Documented by Real Time 3D Echocardiography. | journal=Echocardiography | year= 2015 | volume= 32 | issue= 12 | pages= 1876-9 | pmid=26199144 | doi=10.1111/echo.13015 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26199144  }} </ref> <ref name="pmid26339757">{{cite journal |vauthors=Öztunç F, Atik SU, Güneş AO |title=Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia |journal=Cardiol Young |volume=25 |issue=7 |pages=1411–4 |date=October 2015 |pmid=26339757 |doi=10.1017/S1047951114002261 |url=}}</ref>
*patients with rhabdomyoma should be monitored with [[echocardiography]] and [[electrocardiography]].  


====Adult rhabdomyoma====
====Adult rhabdomyoma====
*In patients with adult rhabdomyoma, nasal oxygen may help patients with breathing difficulties.
*Patients with [[laryngeal]] rhabdomyoma need immediate care such as [[nasal]] oxygen, [[intravenous fluids]] and if respiratory distress develops intubation before admission for surgery and surgical excision. <ref name="pmid24288631">{{cite journal |vauthors=Amelia Souza A, de Araújo VC, Passador Santos F, Ferreira Martinez E, de Menezes Filho JF, Soares de Araujo N, Soares AB |title=Intraoral adult rhabdomyoma: a case report |journal=Case Rep Dent |volume=2013 |issue= |pages=741548 |date=2013 |pmid=24288631 |pmc=3833031 |doi=10.1155/2013/741548 |url=}}</ref>
**In circumstances in which swallowing becomes extremely difficult in adult rhabdomyoma patients, supplemental intravenous fluids may be administered until surgery is performed. Patients with adult rhabdomyoma with problems related to swallowing may need to be placed on a liquid diet.
*Patients with adult rhabdomyoma and shortness of breath should restrain from activities which exacerbate their breathing difficulty.
*Until appropriate treatment can be undertaken, patients with adult rhabdomyoma who are experiencing breathing difficulties should restrict their activities. Patients with cardiac rhabdomyoma should also restrict their activities.<ref name="pmid21464184">{{cite journal| author=Tiberio D, Franz DN, Phillips JR| title=Regression of a cardiac rhabdomyoma in a patient receiving everolimus. | journal=Pediatrics | year= 2011 | volume= 127 | issue= 5 | pages= e1335-7 | pmid=21464184 | doi=10.1542/peds.2010-2910 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21464184  }} </ref><ref name="pmid26339757">{{cite journal| author=Öztunç F, Atik SU, Güneş AO| title=Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia. | journal=Cardiol Young | year= 2015 | volume= 25 | issue= 7 | pages= 1411-4 | pmid=26339757 | doi=10.1017/S1047951114002261 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26339757  }} </ref><ref name="pmid26199144">{{cite journal| author=Wagner R, Riede FT, Seki H, Hornemann F, Syrbe S, Daehnert I et al.| title=Oral Everolimus for Treatment of a Giant Left Ventricular Rhabdomyoma in a Neonate-Rapid Tumor Regression Documented by Real Time 3D Echocardiography. | journal=Echocardiography | year= 2015 | volume= 32 | issue= 12 | pages= 1876-9 | pmid=26199144 | doi=10.1111/echo.13015 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26199144  }} </ref>


====Cardiac rhabdomyoma====
====Cardiac rhabdomyoma====
*The mainstay of therapy for cardiac rhabdomyoma is [[everolimus]].  
*[[Pharmacological]] treatment available for [[fetal]] cardiac rhabdomyoma is [[everolimus]].<ref name="pmid29759095">{{cite journal |vauthors=Martínez-García A, Michel-Macías C, Cordero-González G, Escamilla-Sánchez KI, Aguinaga-Ríos M, Coronado-Zarco A, Cardona-Pérez JA |title=Giant left ventricular rhabdomyoma treated successfully with everolimus: case report and review of literature |journal=Cardiol Young |volume=28 |issue=7 |pages=903–909 |date=July 2018 |pmid=29759095 |doi=10.1017/S1047951118000598 |url=}}</ref>
*Patients with [[arrhythmia]]s are treated with [[antiarrhythmic medications]].
*Patients with [[arrhythmia]]s are treated with [[antiarrhythmic medications]].
*Until appropriate treatment can be undertaken, patients with cardiac rhabdomyoma who are experiencing breathing difficulties should restrict their activities.<ref name="pmid21464184">{{cite journal| author=Tiberio D, Franz DN, Phillips JR| title=Regression of a cardiac rhabdomyoma in a patient receiving everolimus. | journal=Pediatrics | year= 2011 | volume= 127 | issue= 5 | pages= e1335-7 | pmid=21464184 | doi=10.1542/peds.2010-2910 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21464184  }} </ref><ref name="pmid26339757">{{cite journal| author=Öztunç F, Atik SU, Güneş AO| title=Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia. | journal=Cardiol Young | year= 2015 | volume= 25 | issue= 7 | pages= 1411-4 | pmid=26339757 | doi=10.1017/S1047951114002261 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26339757  }} </ref><ref name="pmid26199144">{{cite journal| author=Wagner R, Riede FT, Seki H, Hornemann F, Syrbe S, Daehnert I et al.| title=Oral Everolimus for Treatment of a Giant Left Ventricular Rhabdomyoma in a Neonate-Rapid Tumor Regression Documented by Real Time 3D Echocardiography. | journal=Echocardiography | year= 2015 | volume= 32 | issue= 12 | pages= 1876-9 | pmid=26199144 | doi=10.1111/echo.13015 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26199144  }} </ref>
*Restriction on physical activities in those patients with [[cardiac]] clinical symptoms.
*[[Asymptomatic]] children with [[TSC]] and a rhabdomyoma should have [[echocardiography]] every one to three years until regression of cardiac rhabdomyoma is documented.


====Genital rhabdomyoma====
====Genital rhabdomyoma====
*If symptoms of [[urinary tract obstruction]] develop, patients with genital rhabdomyomas may require [[catheterization]]. Genital rhabdomyoma patients who become pregnant need to be monitored closely, as they may require a [[Cesarean delivery]].
*In patients with [[genital]] rhabdomyoma, urinary tract obstruction may happen, therefore [[catheterization]] use may be necessary in order to avoid [[Urinary tract infections|urinary tract infection]].  
 
*Pregnant patients need to be monitored closely, as they may require a [[cesarean delivery]].<ref name="pmid21992817">{{cite journal |vauthors=Lu DY, Chang S, Cook H, Alizadeh Y, Karam AK, Moatamed NA, Dry SM |title=Genital rhabdomyoma of the urethra in an infant girl |journal=Hum. Pathol. |volume=43 |issue=4 |pages=597–600 |date=April 2012 |pmid=21992817 |doi=10.1016/j.humpath.2011.06.012 |url=}}</ref><ref name="pmid3031168">{{cite journal |vauthors=Dodat H, Paulhac JB, Macabeo V, Bouvier R |title=[Benign tumors of the posterior urethra in children. Apropos of an unusual case of rhabdomyoma of fetal type] |language=French |journal=J Urol (Paris) |volume=93 |issue=1 |pages=43–6 |date=1987 |pmid=3031168 |doi= |url=}}</ref>


=== Surgery ===
=== Surgery ===
====Adult rhabdomyoma====
====Adult rhabdomyoma====
*Surgical resection of the tumor can only be performed for patients with adult rhabdomyoma if [[airway obstruction]] is diagnosed.  
*Surgical resection of the tumor can only be performed for patients with adult rhabdomyoma if [[airway obstruction]] is diagnosed, there have been reports of rare cases of [[laryngeal]] rhabdomyoma which may cause breathing difficulty for patients.<ref name="pmid25992049">{{cite journal |vauthors=Pinho MM, de Carvalho E Castro J, Ramos RG |title=Adult rhabdomyoma of the larynx |journal=Int Arch Otorhinolaryngol |volume=17 |issue=4 |pages=415–8 |date=October 2013 |pmid=25992049 |pmc=4399195 |doi=10.1055/s-0033-1351671 |url=}}</ref>


====Cardiac rhabdomyoma====
====Cardiac rhabdomyoma====
*Surgical intervention is reserved for patients with cardiac rhabdomyomas who have symptoms of severe [[hemodynamic compromise]] or intractable [[arrhythmia]]s. Surgical management involves removal of the intracavitary portion of the tumor without complete excision of the entire lesion.
*In patients with [[cardiac]] rhabdomyoma who have symptoms of severe outflow tract obstruction or [[arrhythmia]]s, surgical intervention can be helpful. Surgical management involves removal of the part of the [[tumor]] causing obstruction without complete excision of the entire lesion.<ref name="pmid30333341">{{cite journal |vauthors=Norawat R, Sarkar D, Maybauer MO |title=Perioperative management of critical right ventricular inflow obstruction from right atrial rhabdomyoma |journal=Ann Card Anaesth |volume=21 |issue=4 |pages=430–432 |date=2018 |pmid=30333341 |pmc=6206783 |doi=10.4103/aca.ACA_233_17 |url=}}</ref>


=== Prevention ===
=== Prevention ===
Line 221: Line 700:
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Orthopedics]]
[[Category:Orthopedics]]
[[Category:Medicine]]

Latest revision as of 04:37, 17 January 2019

Rhabdomyoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rhabdomyoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rhabdomyoma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rhabdomyoma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rhabdomyoma

CDC on Rhabdomyoma

Rhabdomyoma in the news

Blogs on Rhabdomyoma

Directions to Hospitals Treating Rhabdomyoma

Risk calculators and risk factors for Rhabdomyoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]

Synonyms and keywords: Rhabdomyomatous neoplasm; Adult rhabdomyoma; Genital rhabdomyoma; Fetal rhabdomyoma; Rhabdomyomatous mesenchymal hamartomas

Overview

Rhabdomyoma is a benign tumor of striated muscle. Rhabdomyomas are rare and can be classified into cardiac type and extracardiac type. The most common primary benign pediatric tumor of the heart is cardiac rhabdomyoma which can be seen mainly in fetal life and children, second most common primary benign cardiac tumor in children is fibroma. Most tumors regress spontaneously, prognosis depends on the location of tumor and size. Cardiac rhabdomyoma is strongly associated with tuberous sclerosis. Cardiac rhabdomyoma is seen almost always in the pediatric age group and is associated with tuberous sclerosis, neurofibromatosis, and sebaceous adenomas. Extracardiac rhabdomyoma can be divided into three groups (adult, fetal, and genital types) with distinct clinical and morphological differences. The adult type is a slowly growing mass which typically involves the head and neck. Fetal type is seen in the head and neck region. The genital type is almost always found in the vulvovaginal region of older women. Treatment of adult type rhabdomyoma of head and neck depends upon the severity of clinical symptoms.

Classification

Rhabdomyoma may be classified into the following subtypes: [1][2][3][4][5][6]

Neoplastic

Neoplastic rhabdomyomas may be further classified into the following types:

Hamartomataous

Hamartamatous rhabdomyomas may be further classified into the following types:

Staging

There have not been sufficient studies for the staging of rhabdomyoma. There is staging based on site, tumor size and metastases for rhabdomyosarcoma, which is a malignant tumor of striated muscle.

Pathophysiology

Pathogenesis

Cardiac Rhabdomyoma

  • Cardiac rhabdomyoma is typically seen in cases of tuberous sclerosis and the pathogenesis involves mutations in the TSC1 and TSC2 genes.[8]
  • Mutations in the TSC1 and TSC2 genes affect downstream molecular signalling pathways, primarily the mTOR pathway that leads to disrupted cellular growth, proliferation and motility.[9][10]
  • Activation of mTOR pathway leads to increased translation and protein production by ribosomal protein S6 kinase beta-1 (p70S6K) and eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1), contributing to the abnormal cell growth and proliferation
  • Cardiac rhabdomyoma is usually diagnosed during the second or third trimester on ultrasound, rhabdomyoma appears as round, homogeneous, hyperechogenic masses in the ventricles, and they sometimes appear as multiple foci in the ventricles and septal wall. Differential diagnosis between rhabdomyoma, fibroma or myxoma using ultrasonography for a single cardiac mass remains difficult. [11][12]
  • Cells usually lose their ability to divide and undergo apoptosis via a ubiquitin-mediated pathway and regression of the hamartoma ensues.[13]
  • Result can be complete or partial regression of hamartoma tumor.

Extracardiac Rhabdomyoma

  • The pathogenesis of extracardiac rhabdomyoma is largely unknown, however, constitutive activation of the Hedgehog signalling (SHH pathway activation) and association with Gorlin’s syndrome have been implicated as the two key mechanisms leading to development of these soft tissue tumors.[14][15]

Location

Immunohistochemistry

Associated Conditions

Gross Pathology

  • On gross pathology, round or polypoid mass in the region of the neck are characteristic findings of adult rhabdomyoma.
    • Round or lobulated, well-circumscribed masses which can be up to 10 cm in diameter.[19]
    • Isolated or multiple.
    • Solid tan-white homogeneous consistency, often watery and glistening on their cut surface.
    • Infrequently, calcification and hemorrhage.
Cardiac rhabdomyoma Gross. Source: http://peir2.path.uab.edu/pdl/dbra.cgi?uid=default&view_search=1


Microscopic Pathology

fetal rhabdomyoma H&E stain [https:https://en.wikipedia.org/wiki/Rhabdomyoma#/media/File:Fetal_intermediate_cellular_type_rhabdomyoma.JPG source:Jerad M Gardner, MD]


Causes

Differentiating Rhabdomyoma from Other Diseases

  • Rhabdomyomas must be differentiated from other diseases, such as:[27]

Differential Diagnosis of Cardiac Rhabdomyoma

Cardiac rhabdomyoma should be differentiated from other cardiac tumors that present as a cardiac mass. The following are the differentials:[28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][2][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73]

Site of Tumor Malignant Potential Type of Tumor Tissue of Origin Age of Presentation Location Morphology Signs and Symptoms MRI Findings
Systemic Manifestations Cardiac Manifestations Embolic Manifestations
Primary Cardiac Tumor Primary Benign Myxoma
  • Mesenchymal
  • Between third to sixth decade of life
  • Left atrium (75%)
  • Right atrium (15-20%)
  • Arise from border of fossa ovalis
  • 1-15 cm in diameter
  • Pedunculated
  • Polypoid
  • Smooth and lobulated
  • Villous and pappillary appearance associated with embolization
  • Constitutional symptoms
  • Carney complex:
    • Spotty skin pigmentation
    • Endocrinal tumors such as sertoli testicular tumors, pituitary adenomas, thyroid tumors
    • Schwanomma
  • NAME syndrome:
    • Nevi
    • Atrial myxoma
    • Myxoid neurofibroma
    • Ephelides
  • LAMB syndrome:
    • Lentigo (small brown patches on the skin)
    • Atrial myxoma
    • Blue nevi
  • Dyspnea
  • Mitral regurgitation (LA)
  • Right heart failure (RA)
  • Cardiomegaly
  • Pulmonary hypertension and pulmonary emboli (RA)
  • Oval mobile left atrial lesion
  • Heterogenous enhancement
  • Attachment to fossa ovalis
Rhabdomyoma
  • Striated Muscle
  • Majority (80%) in infants (<12 months)
  • Most common cardiac mass in childhood
  • 50-70% of all pediatric tumors
  • Ventricles
  • Interventricular septum
  • 1-3 cm in size
  • Yellow-gray color
  • Firm
  • Circumscribed lobulated
  • Majority multiple if associated with tuberous sclerosis (of those with no association, 50% are single)
  • Associated with tuberous sclerosis:
    • Developmental delay
    • Renal tumors (angiomyolipomas)
    • Phakomas (white retinal spots)
    • Hypomelanic macules (ash leaf spots)
    • Ungal fibromas
    • Facial angiofibromas
    • Headache
    • Blurred vision
    • Arrhythmias
    • Benign brain tumors (cortical tubers, subependymal nodules)
  • Outflow obstruction (both right and left ventricles)
  • Arrhythmias (ventricular pre-excitation, Wolff-Parkinson White syndrome)
  • Spontaneous regression in young cases (< 4 years); seldom regress in adult cases
  • Multiple masses isointense to muscle tissue on T1 images
  • Hyperintense on T2 images
Fibroma
  • Fibrous
  • Children (1/3rd in infants)
  • Ventricles
  • Ventricular septum >Left ventricular free wall > Right ventricle > Atria
  • Central calcification
  • Solitary
  • Cyanosis
  • Atypical chest pain
  • Heart failure
  • Cardiomegaly
  • Biventricular hypertrophy
  • Atrioventricular nodal block
  • Solitary mass
  • Low intensity on T2 weighted image
Fibroelastoma
  • Valvular endocardium
  • Valvular endocardium (Adults-Aortic, children-Tricuspid)
  • Ventrucular surface of aortic and pulmonary valves and atrial surface of atriventricular valves
  • < 1 cm in diameter
  • Solitary
  • Papillary
  • Flower-like appearance with multiple attachments to valve
  • Short pedicle
  • Asymptomatic
  • Association with hypertrophic obstructive cardiomyopathy (HOCM)
  • Subacute bacterial endocarditis
  • Pulmonary embolism
  • T1 and T2 weighted images show uniform intermediate signal intensity similar to myocardium
  • Homogeneous late gadolinium contrast enhancement
Hemangioma
  • Vascular
  • < 1 year to 70 years
  • < 2 % of primary cardiac tumors
  • Right Ventricle
  • Left ventricle
  • Right atrium
  • Small percentage in interatrial septum and left atrium
  • Polypoid
  • Encapsulated
  • Cyanosis
  • Kasabach-Merritt syndrome (giant hemangiomas):
    • Thrombosis
    • Thrombocytopenia
    • Coagulopathy
  • Pericardial effusions
  • CHF
  • Arrhythmias
  • Pulmonary embolism
  • Ischemic stroke
  • Intermediate density on T1 images
  • Hypointense on T2 images
  • Multicystic enhancing lesion
  • Involvement of epicardium or pericardium
Lipoma
  • Adipose
  • Between fourth to sixth decade of life
  • Left ventricle (most commonly subendocardium)
  • Right atrium
  • Sessile and small (specially subendocardial that protrude into cardiac chambers)
  • Broad pedicle
  • Growth into pericardial space
  • Asymptomatic
  • Dyspnea
  • Local compression (subepicardial)
  • Arrhythmia
  • Ischemic stroke
  • Epicardial on intramural lesion
  • High intensity on T1 weighted image
  • Drop out on fat saturation images
Paraganglioma
  • Nervous (chromaffin cells of the sympathetic ganglia)
  • Average age of presentation is 11-13 years
  • Left atrium (under the aorta and the pulmonary artery)
  • Interatrial septum
  • Left ventricle
  • Right ventricular outflow tract
  • 3-8 cm
  • Well-defined
  • Broad base
  • Encapsulated
  • Heterogeneous
  • Hypervascular
  • Majority asymptomatic
  • May present with symptoms of catecholamine excess:
    • Tachycardia
    • Hypertension
    • Palipitations
    • Fever
    • Diaphoresis
  • Positive for chromogranin and synaptophysin
  • Association with succinate dehydrogenase (SDH) mutation
  • Dyspnea
  • Valvular obstruction (murmurs)
  • Acute coronary syndrome (anginal pain)
  • Enascement of coronary arteries by tumor
  • Well defined lesion arising from atrial walls or septum
  • Bright on T2 weighted imaging
Atrioventricular Node Tumor
  • Endodermal
  • Average age of diagnosis is 38 years
  • Female to male ratio 3:1
  • Triangle of Koch in the AV nodal region of the atrial septum
  • 2 mm to 2 cm
  • Multiple
  • Cystic
  • Thickening of the atrial septum
  • Most common cardiac tumor leading to sudden death
  • Emery-Dreifuss muscular dystrophy
  • Midline developmental defects along the central vertical body axis:
    • Thyroglossal duct cysts
    • Cysts in the ovaries, breasts
    • Ventricular septal defect
    • Encephalocele
  • Positive for:
    • Cytokeratin CAM5.2
    • Cytokeratin AE1/AE3
    • Cytokeratin 34βE12
    • Cytokeratin 5/6 (CK5/6)
    • Cytokeratin 7 (CK7)
    • Epithelial membrane antigen (EMA)
    • Carcinoembryonic antigen (CEA)
    • Carbohydrate antigen (CA)19.9, p63, bcl2, galectin 3
  • Palpitations
  • Dyspnea
  • Chest pain
  • Diziness
  • Syncope
  • Complete heart block
  • Partial AV block
  • Paroxysmal atrial arrhythmia
  • Spontaneous intermittent pre-excitation
  • Myocardial infarction
  • Ischemic stroke
  • Hypointense cardiac mass on standard imaging
  • Hyperintensity on late gadolinium enhancement (LGE) images with heterogeneous contrast enhancement
Lipomatous hypertrophy of the interatrial septum
  • Adipose
  • > 60 years
  • Limbus of the fossa ovalis (sparing fossa ovalis membrane)
  • > 2 cm
  • Interatrial septum maybe upto 7 cm in thickness
  • Mostly asymotmatic
  • May present with obstructive symptoms such as syncope in rare cases of extension into superior vena cava
  • Associated with:
    • Increased age
    • Obesity
    • Arrhythmias
  • Palpitations
  • Dyspnea
  • Fatigue
-
  • Diffuse or nodular thickening of atrial walls
  • Hyperintense to normal myocardium
  • Hypointense to pericardial and posterior mediastinal fat
Primary Malignant Fibrosarcoma
  • Fibrous
  • Left sided (atrial mostly)
  • Sessile or pedunculated protruding masses in ventricular cavities
  • Soft
  • Lobulated
  • Gelatinous
  • Fever
  • Fatigue
  • Malaise
  • Weight loss
  • Cytoplasmatic positivity for a-SMA
  • CHF
  • Pericardial infiltration (effusions)
  • Pulmonary embolism
  • Ischemic stroke
  • Metastasis
  • Heterogenous or isointense to myocardium on T1 weighted images
Angiosarcoma
  • Vascular
  • Third to fifth decade of life
  • Right atrium
  • Broad-based
  • Internal hemmorrhage
  • Fever
  • Fatigue
  • Weight loss
  • Congestion
  • Superior vena cava syndrome
  • Embolic stroke
  • Endothelial marker D2-40
  • Dyspnea
  • CHF
  • Pericardial effusions
  • Cardiac tamponade
  • Pulmonary embolism
  • Ischemic stroke
  • Metastasis
  • Arterial phase enhancement
Rhabdomyosarcoma
  • Mesenchymal
  • Most common primary sarcoma of children
  • Average age of presentation is 20 years
  • Left sided (atrial mostly)
  • Multiple
  • Three types:
    • Embryonic
    • Pleomorphic
    • Alveolar
  • Fever
  • Fatigue
  • Weight loss
  • Metastasize to lung and lymph nodes
  • CHF
  • Arrhythmias
  • Pulmonary embolism
  • Ischemic stroke
  • Metastasis
  • Intermediate-to-hypointensity compared with muscle on T1 images
  • Hyperintense on T2-weighted imaging with heterogeneous contrast enhancement
Lymphoma
  • Lymphoid
  • First to ninth decade of life
  • Males > females
  • Right sided mostly
  • Majority solitary (1/3rd multiple)
  • Associations:
    • Chronic immunosupression
    • Epstein Barr virus
    • HIV
    • Diffuse large B cell lymphoma
  • May involve epicardium and pericardium
  • Pulmonary embolism
  • Ischemic stroke
  • Metastasis
Secondary CardiacTumor Metastastatic Malignant Metastasis
  • Skin (Melanoma)
  • Lung carcinoma
  • Lymph (leukemia and lymphoma)
  • Breast carcinoma
  • Smooth muscle (Esophageal carcinoma)
  • Any age
  • Tumors metastasizing via hematogenous route present as multiple intramyocardial masses:
    • Melanoma
    • Leukemia
    • Sarcoma
  • Tumors metastasizing via venous system as right sided mass:
    • Renal cell carcinoma
    • Hepatocellular carcinoma
  • Lung tumor metastasizes to left atrium
  • Multiple
  • Fever
  • Fatigue
  • Weight loss
  • Dysphagia
  • Lymphadenopathy
  • Night sweats
  • Pericardial effusions
  • Dyspnea
  • Arrhytmia
  • Outflow obstruction
  • Pulmonary embolism
  • Ischemic stroke
  • Metastasis

Epidemiology and Demographics

  • Cardiac rhabdomyomas are usually detected during the first year of life or before birth and accounts for majority of all primary cardiac tumors.[24][74][75]
  • Worldwide, rhabdomyoma is rare.
  • Most of patients with tuberous sclerosis develop a cardiac rhabdomyoma. Similarly, children diagnosed with cardiac rhabdomyomas demonstrate radiologic or clinical findings of tuberous sclerosis or have a positive family history. Rhabdomyoma is extremely rare in the United States. Rhabdomyoma has a relative incidence of 5.8%.

Age

  • Adult rhabdomyoma is more commonly observed among patients aged greater than 40 years old.[12]
  • Fetal rhabdomyoma is more commonly observed among patients aged between birth and 3 years.
  • Cardiac rhabdomyoma is more commonly observed among patients in the pediatric age group.
  • Genital rhabdomyoma is more commonly observed among patients in the young and middle-aged women.
  • Rhabdomyomatous mesenchymal hamartomas of the skin is more commonly observed among newborns and infants.[1]

Gender

  • Cardiac rhabdomyoma affects men and women equally.[15][76]
  • Rhabdomyomatous mesenchymal hamartoma of skin is extremely rare in both genders.
  • Males are more commonly affected with adult rhabdomyoma than females.
  • Males are more commonly affected with fetal rhabdomyoma than females.
  • Females are more commonly affected with genital rhabdomyoma than males.

Race

  • There is no racial predilection for rhabdomyomas.

Risk Factors

  • There are no established risk factors for rhabdomyoma.

Natural History, Complications and Prognosis

Natural History

Complications

Prognosis

  • prognosis is generally good; the survival rate of patients with benign rhabdomyoma is excellent, depending on location of tumor, prognosis may change.[79]
  • Rhabdomyomas on mitral or tricuspid valves can lead to regurgitation or obstruction of outflow tract thus poor prognosis.[80]
  • The long-term prognosis of cardiac rhabdomyoma is affected by the neurologic manifestations associated with tuberous sclerosis.[81]
  • The prognosis of patients with rhabdomyomas depends mainly on the size, location, number of the lesions, associated anomalies such as tuberous sclerosis.
  • Metastases have not been associated with rhabdomyoma.

Diagnosis

Symptoms

  • Symptoms of adult rhabdomyoma may include:[82]
  • Symptoms of genital rhabdomyoma may include the following:
  • Symptoms of cardiac rhabdomyoma may include the following:

Physical Examination

  • Physical examination may be remarkable for:
  • The presence of a round or polypoid mass in the region of the neck in adult rhabdomyoma
  • Subcutaneous masses in the head and neck regions in fetal rhabdomyoma
  • Vaginal masses in genital rhabdomyoma
  • Cardiac rhabdomyoma may present with mitral or tricuspid regurgitation murmur.[85]

Laboratory Findings

Imaging Findings

  • MRI is the imaging modality of choice for rhabdomyoma. Chest CT scan may be helpful in the diagnosis of cardiac rhabdomyoma.
  • On ultrasound, rhabdomyoma is identified by single or multi foci hyper echoic mass(es) located adjacent to the myocardium.[28]
  • X-Rays of the chest and affected areas of the body may be helpful in the diagnosis of rhabdomyomas.
fetal cardiac rhabdomyoma source:Case courtesy of Dr Effendi Mansoor, <a href="https://radiopaedia.org/">Radiopaedia.org</a>. From the case <a href="https://radiopaedia.org/cases/17302">rID: 17302</a>


Other Diagnostic Studies

  • Rhabdomyoma may also be diagnosed using biopsy since overlap in morphologic features between rhabdomyosarcoma (RMS) vs. rhabdomyoma makes differential diagnosis difficult.[86]
  • Any masses, including those found in the head and neck of patients with adult rhabdomyoma, should be biopsied to establish a diagnosis.

Treatment

Medical Therapy

Adult rhabdomyoma

  • Patients with laryngeal rhabdomyoma need immediate care such as nasal oxygen, intravenous fluids and if respiratory distress develops intubation before admission for surgery and surgical excision. [17]
  • Patients with adult rhabdomyoma and shortness of breath should restrain from activities which exacerbate their breathing difficulty.

Cardiac rhabdomyoma

Genital rhabdomyoma

Surgery

Adult rhabdomyoma

  • Surgical resection of the tumor can only be performed for patients with adult rhabdomyoma if airway obstruction is diagnosed, there have been reports of rare cases of laryngeal rhabdomyoma which may cause breathing difficulty for patients.[92]

Cardiac rhabdomyoma

  • In patients with cardiac rhabdomyoma who have symptoms of severe outflow tract obstruction or arrhythmias, surgical intervention can be helpful. Surgical management involves removal of the part of the tumor causing obstruction without complete excision of the entire lesion.[93]

Prevention

  • There are no primary preventive measures available for rhabdomyoma.

References

  1. 1.0 1.1 McKinnon EL, Rand AJ, Selim MA, Fuchs HE, Buckley AF, Cummings TJ (October 2015). "Rhabdomyomatous mesenchymal hamartoma presenting as a sacral skin tag in two neonates with spinal dysraphism". J. Cutan. Pathol. 42 (10): 774–8. doi:10.1111/cup.12538. PMID 25989364.
  2. 2.0 2.1 Beghetti M, Gow RM, Haney I, Mawson J, Williams WG, Freedom RM (1997). "Pediatric primary benign cardiac tumors: a 15-year review". Am Heart J. 134 (6): 1107–14. PMID 9424072.
  3. 3.0 3.1 Becker AE (2000). "Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians". Pediatr Cardiol. 21 (4): 317–23. doi:10.1007/s002460010071. PMID 10865004.
  4. Elderkin RA, Radford DJ (2002). "Primary cardiac tumours in a paediatric population". J Paediatr Child Health. 38 (2): 173–7. PMID 12031001.
  5. Kocabaş A, Ekici F, Cetin Iİ, Emir S, Demir HA, Arı ME; et al. (2013). "Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome". Pediatr Hematol Oncol. 30 (2): 71–9. doi:10.3109/08880018.2012.734896. PMID 23151153.
  6. 6.0 6.1 Lu DY, Chang S, Cook H, Alizadeh Y, Karam AK, Moatamed NA, Dry SM (April 2012). "Genital rhabdomyoma of the urethra in an infant girl". Hum. Pathol. 43 (4): 597–600. doi:10.1016/j.humpath.2011.06.012. PMID 21992817.
  7. White LR, Agrawal V, Sutton L, Balbosa AC (June 2015). "Rhabdomyomatous mesenchymal hamartoma of the face causing trigeminal neuralgia". Am J Case Rep. 16: 338–40. doi:10.12659/AJCR.893719. PMC 4460909. PMID 26037964.
  8. "Enzinger and Weiss's Soft Tissue Tumors - 6th Edition".
  9. Kotulska K, Larysz-Brysz M, Grajkowska W, Jóźwiak J, Włodarski P, Sahin M, Lewin-Kowalik J, Domańska-Pakieła D, Jóźwiak S (2009). "Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities". Pediatr. Dev. Pathol. 12 (2): 89–95. doi:10.2350/06-11-0191.1. PMID 17990907.
  10. Krueger DA, Northrup H (October 2013). "Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference". Pediatr. Neurol. 49 (4): 255–65. doi:10.1016/j.pediatrneurol.2013.08.002. PMID 24053983.
  11. 11.0 11.1 Sharma N, Sharma S, Thiek JL, Ahanthem SS, Kalita A, Lynser D (2017). "Maternal and Fetal Tuberous Sclerosis: Do We Know Enough as an Obstetrician?". J Reprod Infertil. 18 (2 pages=257–260). PMC 5565905. PMID 28868251.
  12. 12.0 12.1 Bejiqi R, Retkoceri R, Bejiqi H (April 2017). "Prenatally Diagnosis and Outcome of Fetuses with Cardiac Rhabdomyoma - Single Centre Experience". Open Access Maced J Med Sci. 5 (2): 193–196. doi:10.3889/oamjms.2017.040. PMC 5420773. PMID 28507627.
  13. Wu SS, Collins MH, de Chadarévian JP (2002). "Study of the regression process in cardiac rhabdomyomas". Pediatr. Dev. Pathol. 5 (1): 29–36. PMID 11815866.
  14. Hettmer S, Teot LA, Kozakewich H, Werger AM, Davies KJ, Fletcher CD, Grier HE, Rodriguez-Galindo C, Wagers AJ (March 2015). "Myogenic tumors in nevoid Basal cell carcinoma syndrome". J. Pediatr. Hematol. Oncol. 37 (2): 147–9. doi:10.1097/MPH.0000000000000115. PMC 4127382. PMID 24517962.
  15. 15.0 15.1 de Trey LA, Schmid S, Huber GF (2013). "Multifocal adult rhabdomyoma of the head and neck manifestation in 7 locations and review of the literature". Case Rep Otolaryngol. 2013: 758416. doi:10.1155/2013/758416. PMC 3697226. PMID 23841004.
  16. 16.0 16.1 Bjørndal Sørensen K, Godballe C, Ostergaard B, Krogdahl A (March 2006). "Adult extracardiac rhabdomyoma: light and immunohistochemical studies of two cases in the parapharyngeal space". Head Neck. 28 (3): 275–9. doi:10.1002/hed.20358. PMID 16419079.
  17. 17.0 17.1 Amelia Souza A, de Araújo VC, Passador Santos F, Ferreira Martinez E, de Menezes Filho JF, Soares de Araujo N, Soares AB (2013). "Intraoral adult rhabdomyoma: a case report". Case Rep Dent. 2013: 741548. doi:10.1155/2013/741548. PMC 3833031. PMID 24288631.
  18. Castilla Cabanes E, Lacambra Blasco I (2014). "Multiple cardiac rhabdomyomas, wolff-Parkinson-white syndrome, and tuberous sclerosis: an infrequent combination". Case Rep Pediatr. 2014: 973040. doi:10.1155/2014/973040. PMC 4189844. PMID 25328743.
  19. Kassop D, Donovan MS, Cheezum MK, Nguyen BT, Gambill NB, Blankstein R, Villines TC (2014). "Cardiac Masses on Cardiac CT: A Review". Curr Cardiovasc Imaging Rep. 7: 9281. doi:10.1007/s12410-014-9281-1. PMC 4090749. PMID 25018846.
  20. 20.0 20.1 Rosenberg AS, Kirk J, Morgan MB (April 2002). "Rhabdomyomatous mesenchymal hamartoma: an unusual dermal entity with a report of two cases and a review of the literature". J. Cutan. Pathol. 29 (4): 238–43. PMID 12028157.
  21. Fenoglio JJ, MCAllister HA, Ferrans VJ (August 1976). "Cardiac rhabdomyoma: a clinicopathologic and electron microscopic study". Am. J. Cardiol. 38 (2): 241–51. PMID 952267.
  22. Burke A, Virmani R (2008). "Pediatric heart tumors". Cardiovasc Pathol. 17 (4): 193–8. doi:10.1016/j.carpath.2007.08.008. PMID 18402818.
  23. Vaughan CJ, Veugelers M, Basson CT (2001). "Tumors and the heart: molecular genetic advances". Curr Opin Cardiol. 16 (3): 195–200. PMID 11357016.
  24. 24.0 24.1 Isaacs H (2004). "Fetal and neonatal cardiac tumors". Pediatr Cardiol. 25 (3): 252–73. doi:10.1007/s00246-003-0590-4. PMID 15360117.
  25. Krapp M, Baschat AA, Gembruch U, Gloeckner K, Schwinger E, Reusche E (1999). "Tuberous sclerosis with intracardiac rhabdomyoma in a fetus with trisomy 21: case report and review of literature". Prenat Diagn. 19 (7): 610–3. PMID 10419607.
  26. Goldenberg DL (November 1989). "A review of the role of tricyclic medications in the treatment of fibromyalgia syndrome". J Rheumatol Suppl. 19: 137–9. PMID 2691673.
  27. Nasr E, Ibrahim M, Yacoub M (January 2017). "Heart failure in a neonate with multiple cardiac masses". Heart. 103 (1): 18. doi:10.1136/heartjnl-2016-310251. PMID 27655257.
  28. 28.0 28.1 Mankad R, Herrmann J (December 2016). "Cardiac tumors: echo assessment". Echo Res Pract. 3 (4): R65–R77. doi:10.1530/ERP-16-0035. PMC 5292983. PMID 27600455.
  29. Zaragoza-Macias E, Zaragosa-Macias E, Chen MA, Gill EA (February 2012). "Real time three-dimensional echocardiography evaluation of intracardiac masses". Echocardiography. 29 (2): 207–19. doi:10.1111/j.1540-8175.2011.01627.x. PMID 22283202.
  30. Larrieu AJ, Jamieson WR, Tyers GF, Burr LH, Munro AI, Miyagishima RT, Gerein AN, Allen P (March 1982). "Primary cardiac tumors: experience with 25 cases". J. Thorac. Cardiovasc. Surg. 83 (3): 339–48. PMID 7062746.
  31. Molina JE, Edwards JE, Ward HB (August 1990). "Primary cardiac tumors: experience at the University of Minnesota". Thorac Cardiovasc Surg. 38 Suppl 2: 183–91. doi:10.1055/s-2007-1014064. PMID 2237900.
  32. Tazelaar HD, Locke TJ, McGregor CG (October 1992). "Pathology of surgically excised primary cardiac tumors". Mayo Clin. Proc. 67 (10): 957–65. PMID 1434856.
  33. Sarjeant JM, Butany J, Cusimano RJ (2003). "Cancer of the heart: epidemiology and management of primary tumors and metastases". Am J Cardiovasc Drugs. 3 (6): 407–21. doi:10.2165/00129784-200303060-00004. PMID 14728061.
  34. St John Sutton MG, Mercier LA, Giuliani ER, Lie JT (June 1980). "Atrial myxomas: a review of clinical experience in 40 patients". Mayo Clin. Proc. 55 (6): 371–6. PMID 7382545.
  35. Pinede L, Duhaut P, Loire R (May 2001). "Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases". Medicine (Baltimore). 80 (3): 159–72. PMID 11388092.
  36. Reynen K (December 1995). "Cardiac myxomas". N. Engl. J. Med. 333 (24): 1610–7. doi:10.1056/NEJM199512143332407. PMID 7477198.
  37. Javed A, Zalawadiya S, Kovach J, Afonso L (March 2014). "Aortic valve myxoma at the extreme age: a review of literature". BMJ Case Rep. 2014. doi:10.1136/bcr-2013-202689. PMC 3962858. PMID 24642215.
  38. Lee VH, Connolly HM, Brown RD (August 2007). "Central nervous system manifestations of cardiac myxoma". Arch. Neurol. 64 (8): 1115–20. doi:10.1001/archneur.64.8.1115. PMID 17698701.
  39. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL (July 1985). "The complex of myxomas, spotty pigmentation, and endocrine overactivity". Medicine (Baltimore). 64 (4): 270–83. PMID 4010501.
  40. McAllister HA, Hall RJ, Cooley DA (February 1999). "Tumors of the heart and pericardium". Curr Probl Cardiol. 24 (2): 57–116. PMID 10028128.
  41. Klarich KW, Enriquez-Sarano M, Gura GM, Edwards WD, Tajik AJ, Seward JB (September 1997). "Papillary fibroelastoma: echocardiographic characteristics for diagnosis and pathologic correlation". J. Am. Coll. Cardiol. 30 (3): 784–90. PMID 9283541.
  42. Tamin SS, Maleszewski JJ, Scott CG, Khan SK, Edwards WD, Bruce CJ, Oh JK, Pellikka PA, Klarich KW (June 2015). "Prognostic and Bioepidemiologic Implications of Papillary Fibroelastomas". J. Am. Coll. Cardiol. 65 (22): 2420–9. doi:10.1016/j.jacc.2015.03.569. PMID 26046736.
  43. Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BC, Sacchi TJ (September 2003). "Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases". Am. Heart J. 146 (3): 404–10. doi:10.1016/S0002-8703(03)00249-7. PMID 12947356.
  44. 44.0 44.1 Smythe JF, Dyck JD, Smallhorn JF, Freedom RM (November 1990). "Natural history of cardiac rhabdomyoma in infancy and childhood". Am. J. Cardiol. 66 (17): 1247–9. PMID 2239731.
  45. 45.0 45.1 Jacobs JP, Konstantakos AK, Holland FW, Herskowitz K, Ferrer PL, Perryman RA (November 1994). "Surgical treatment for cardiac rhabdomyomas in children". Ann. Thorac. Surg. 58 (5): 1552–5. PMID 7979700.
  46. Elbardissi AW, Dearani JA, Daly RC, Mullany CJ, Orszulak TA, Puga FJ, Schaff HV (September 2008). "Survival after resection of primary cardiac tumors: a 48-year experience". Circulation. 118 (14 Suppl): S7–15. doi:10.1161/CIRCULATIONAHA.107.783126. PMID 18824772.
  47. Basu S, Folliguet T, Anselmo M, Greengart A, Sabado M, Cunningham JN, Jacobowitz IJ (April 1994). "Lipomatous hypertrophy of the interatrial septum". Cardiovasc Surg. 2 (2): 229–31. PMID 8049952.
  48. Simpson L, Kumar SK, Okuno SH, Schaff HV, Porrata LF, Buckner JC, Moynihan TJ (June 2008). "Malignant primary cardiac tumors: review of a single institution experience". Cancer. 112 (11): 2440–6. doi:10.1002/cncr.23459. PMID 18428209.
  49. Vander Salm TJ (April 2000). "Unusual primary tumors of the heart". Semin. Thorac. Cardiovasc. Surg. 12 (2): 89–100. PMID 10807431.
  50. Petersen CD, Robinson WA, Kurnick JE (1976). "Involvement of the heart and pericardium in the malignant lymphomas". Am. J. Med. Sci. 272 (2): 161–5. PMID 1008078.
  51. Ragland MM, Tak T (March 2006). "The role of echocardiography in diagnosing space-occupying lesions of the heart". Clin Med Res. 4 (1): 22–32. PMC 1447535. PMID 16595790.
  52. Miguel CE, Bestetti RB (June 2011). "Primary cardiac lymphoma". Int. J. Cardiol. 149 (3): 358–63. doi:10.1016/j.ijcard.2010.02.016. PMID 20227122.
  53. Grebenc ML, Rosado de Christenson ML, Burke AP, Green CE, Galvin JR (2000). "Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation". Radiographics. 20 (4): 1073–103, quiz 1110–1, 1112. doi:10.1148/radiographics.20.4.g00jl081073. PMID 10903697.
  54. Grinda JM, Couetil JP, Chauvaud S, D'Attellis N, Berrebi A, Fabiani JN, Deloche A, Carpentier A (January 1999). "Cardiac valve papillary fibroelastoma: surgical excision for revealed or potential embolization". J. Thorac. Cardiovasc. Surg. 117 (1): 106–10. PMID 9869763.
  55. Webb DW, Thomas RD, Osborne JP (March 1993). "Cardiac rhabdomyomas and their association with tuberous sclerosis". Arch. Dis. Child. 68 (3): 367–70. PMC 1793857. PMID 8466239.
  56. Yoshitake I, Hata M, Sezai A, Niino T, Unosawa S, Shimura K, Kasamaki Y, Minami K (September 2009). "Cardiac angiosarcoma with cardiac tamponade diagnosed as a ruptured aneurysm of the sinus valsalva". Jpn. J. Clin. Oncol. 39 (9): 612–5. doi:10.1093/jjco/hyp044. PMID 19493870.
  57. Parissis H, Akbar MT, Young V (October 2010). "Primary leiomyosarcoma of the right atrium: a case report and literature update". J Cardiothorac Surg. 5: 80. doi:10.1186/1749-8090-5-80. PMC 2964688. PMID 20939891.
  58. Gulati G, Sharma S, Kothari SS, Juneja R, Saxena A, Talwar KK (2004). "Comparison of echo and MRI in the imaging evaluation of intracardiac masses". Cardiovasc Intervent Radiol. 27 (5): 459–69. doi:10.1007/s00270-004-0123-4. PMID 15383848.
  59. Narin B, Arman A, Arslan D, Simşek M, Narin A (February 2010). "Assessment of cardiac masses: magnetic resonance imaging versus transthoracic echocardiography". Anadolu Kardiyol Derg. 10 (1): 69–74. PMID 20150010.
  60. "academic.oup.com".
  61. Ismail I, Al-Khafaji K, Mutyala M, Aggarwal S, Cotter W, Hakim H, Khosla S, Arora R (2015). "Cardiac lipoma". J Community Hosp Intern Med Perspect. 5 (5): 28449. doi:10.3402/jchimp.v5.28449. PMC 4612478. PMID 26486106.
  62. D'Souza J, Shah R, Abbass A, Burt JR, Goud A, Dahagam C (January 2017). "Invasive Cardiac Lipoma: a case report and review of literature". BMC Cardiovasc Disord. 17 (1): 28. doi:10.1186/s12872-016-0465-2. PMC 5237479. PMID 28088193.
  63. Yadav, Pradeep K.; Baquero, Giselle A.; Malysz, Jozef; Kelleman, John; Gilchrist, Ian C. (2014). "Cardiac Paraganglioma". Circulation: Cardiovascular Interventions. 7 (6): 851–856. doi:10.1161/CIRCINTERVENTIONS.114.001856. ISSN 1941-7640.
  64. Tahir M, Noor SJ, Herle A, Downing S (2009). "Right atrial paraganglioma: a rare primary cardiac neoplasm as a cause of chest pain". Tex Heart Inst J. 36 (6): 594–7. PMC 2801953. PMID 20069088.
  65. Hamilton BH, Francis IR, Gross BH, Korobkin M, Shapiro B, Shulkin BL, Deeb CM, Orringer MB (January 1997). "Intrapericardial paragangliomas (pheochromocytomas): imaging features". AJR Am J Roentgenol. 168 (1): 109–13. doi:10.2214/ajr.168.1.8976931. PMID 8976931.
  66. Shih, Wei-Jen; McCullough, Scott; Smith, Mary (1993). "Diagnostic imagings for primary cardiac fibrosarcoma". International Journal of Cardiology. 39 (2): 157–161. doi:10.1016/0167-5273(93)90028-F. ISSN 0167-5273.
  67. Arai T, Kurashima C, Wada S, Chida K, Ohkawa S (November 1998). "Histological evidence for cell proliferation activity in cystic tumor (endodermal heterotopia) of the atrioventricular node". Pathol. Int. 48 (11): 917–23. PMID 9832064.
  68. Wolf PL, Bing R (November 1965). "The smallest tumor which causes sudden death". JAMA. 194 (6): 674–5. PMID 5897246.
  69. Burke AP, Anderson PG, Virmani R, James TN, Herrera GA, Ceballos R (October 1990). "Tumor of the atrioventricular nodal region. A clinical and immunohistochemical study". Arch. Pathol. Lab. Med. 114 (10): 1057–62. PMID 2222148.
  70. Burke A, Tavora F (April 2016). "The 2015 WHO Classification of Tumors of the Heart and Pericardium". J Thorac Oncol. 11 (4): 441–52. doi:10.1016/j.jtho.2015.11.009. PMID 26725181.
  71. Tran, Thao T; Starnes, Vaughn; Wang, Xuedong; Getzen, James; Ross, Brian D (2009). "Cardiovascular magnetics resonance diagnosis of cystic tumor of the atrioventricular node". Journal of Cardiovascular Magnetic Resonance. 11 (1): 13. doi:10.1186/1532-429X-11-13. ISSN 1532-429X.
  72. Tatli, Servet; O'Gara, Patrick Thomas; Lambert, Jarvis; Kwong, Raymond; Byrne, John Gerald; Yucel, E. Kent (2004). "MRI of Atypical Lipomatous Hypertrophy of the Interatrial Septum". American Journal of Roentgenology. 182 (3): 598–600. doi:10.2214/ajr.182.3.1820598. ISSN 0361-803X.
  73. Saboo, Sachin S.; Krajewski, Katherine M.; Zukotynski, Katherine; Howard, Stephanie; Jagannathan, Jyothi P.; Hornick, Jason L.; Ramaiya, Nikhil (2012). "Imaging Features of Primary and Secondary Adult Rhabdomyosarcoma". American Journal of Roentgenology. 199 (6): W694–W703. doi:10.2214/AJR.11.8213. ISSN 0361-803X.
  74. Delides A, Petrides N, Banis K (2005). "Multifocal adult rhabdomyoma of the head and neck: a case report and literature review". Eur Arch Otorhinolaryngol. 262 (6): 504–6. doi:10.1007/s00405-004-0840-y. PMID 15942804.
  75. Ramadani N, Kreshnike KD, Muçaj S, Kabashi S, Hoxhaj A, Jerliu N, Bejiçi R (April 2016). "MRI Verification of a Case of Huge Infantile Rhabdomyoma". Acta Inform Med. 24 (2): 146–8. doi:10.5455/aim.2016.24.146-148. PMC 4851540. PMID 27147810.
  76. Takeyama J, Hayashi T, Sanada T, Shimanuki Y, Saito M, Shirane R (April 2005). "Rhabdomyomatous mesenchymal hamartoma associated with nasofrontal meningocele and dermoid cyst". J. Cutan. Pathol. 32 (4): 310–3. doi:10.1111/j.0303-6987.2005.00312.x. PMID 15769282.
  77. Barnes BT, Procaccini D, Crino J, Blakemore K, Sekar P, Sagaser KG, Jelin AC, Gaur L (May 2018). "Maternal Sirolimus Therapy for Fetal Cardiac Rhabdomyomas". N. Engl. J. Med. 378 (19): 1844–1845. doi:10.1056/NEJMc1800352. PMC 6201692. PMID 29742370.
  78. Hinton RB, Prakash A, Romp RL, Krueger DA, Knilans TK (November 2014). "Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group". J Am Heart Assoc. 3 (6): e001493. doi:10.1161/JAHA.114.001493. PMC 4338742. PMID 25424575.
  79. Linnemeier L, Benneyworth BD, Turrentine M, Rodefeld M, Brown J (April 2015). "Pediatric cardiac tumors: a 45-year, single-institution review". World J Pediatr Congenit Heart Surg. 6 (2): 215–9. doi:10.1177/2150135114563938. PMID 25870340.
  80. Wang Y, Wang X, Xiao Y (February 2016). "Surgical treatment of primary cardiac valve tumor: early and late results in eight patients". J Cardiothorac Surg. 11: 31. doi:10.1186/s13019-016-0406-2. PMC 4759914. PMID 26891966.
  81. Chung C, Lawson JA, Sarkozy V, Riney K, Wargon O, Shand AW, Cooper S, King H, Kennedy SE, Mowat D (November 2017). "Early Detection of Tuberous Sclerosis Complex: An Opportunity for Improved Neurodevelopmental Outcome". Pediatr. Neurol. 76: 20–26. doi:10.1016/j.pediatrneurol.2017.05.014. PMID 28811058. Vancouver style error: initials (help)
  82. Altissimi G, Ralli M, Sementilli G, Fiorentino F, Ciofalo A, Greco A, de Vincentiis M, Corsi A, Cianfrone G (2017). "Adult-Type Rhabdomyoma of the Larynx: Clinicopathologic Study of an Uncommon Tumor in a Rare Location". Case Rep Otolaryngol. 2017: 7186768. doi:10.1155/2017/7186768. PMC 5727691. PMID 29318074.
  83. Lee JP, Blake Sullivan C, Bayon R, Shearer AE, Robinson RA (December 2018). "Adult type rhabdomyoma presenting as a parathyroid adenoma". Head Neck. doi:10.1002/hed.25419. PMID 30537102.
  84. Bosi G, Lintermans JP, Pellegrino PA, Svaluto-Moreolo G, Vliers A (1996). "The natural history of cardiac rhabdomyoma with and without tuberous sclerosis". Acta Paediatr. 85 (8): 928–31. PMID 8863873.
  85. Ono M, Boethig D, Akin E, Goerler H, Breymann T (March 2007). "Coexistent cardiac rhabdomyoma with mitral valve anomaly in patients with tuberous sclerosis: a case report". Thorac Cardiovasc Surg. 55 (2): 120–1. doi:10.1055/s-2006-924243. PMID 17377866.</ref <nowiki><nowiki>*</nowiki></nowiki>It can present with [[seizures]] or [[cerebral palsy]] if [[tuberous sclerosis]] is involved.<ref name="pmid21173003">Staley BA, Vail EA, Thiele EA (January 2011). "Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs". Pediatrics. 127 (1): e117–25. doi:10.1542/peds.2010-0192. PMC 3010088. PMID 21173003.
  86. Zhang N, Zeng Z, Li S, Wang F, Huang P (August 2018). "High expression of EZH2 as a marker for the differential diagnosis of malignant and benign myogenic tumors". Sci Rep. 8 (1): 12331. doi:10.1038/s41598-018-30648-7. PMC 6098067. PMID 30120321.
  87. Tiberio D, Franz DN, Phillips JR (2011). "Regression of a cardiac rhabdomyoma in a patient receiving everolimus". Pediatrics. 127 (5): e1335–7. doi:10.1542/peds.2010-2910. PMID 21464184.
  88. Wagner R, Riede FT, Seki H, Hornemann F, Syrbe S, Daehnert I; et al. (2015). "Oral Everolimus for Treatment of a Giant Left Ventricular Rhabdomyoma in a Neonate-Rapid Tumor Regression Documented by Real Time 3D Echocardiography". Echocardiography. 32 (12): 1876–9. doi:10.1111/echo.13015. PMID 26199144.
  89. Öztunç F, Atik SU, Güneş AO (October 2015). "Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia". Cardiol Young. 25 (7): 1411–4. doi:10.1017/S1047951114002261. PMID 26339757.
  90. Martínez-García A, Michel-Macías C, Cordero-González G, Escamilla-Sánchez KI, Aguinaga-Ríos M, Coronado-Zarco A, Cardona-Pérez JA (July 2018). "Giant left ventricular rhabdomyoma treated successfully with everolimus: case report and review of literature". Cardiol Young. 28 (7): 903–909. doi:10.1017/S1047951118000598. PMID 29759095.
  91. Dodat H, Paulhac JB, Macabeo V, Bouvier R (1987). "[Benign tumors of the posterior urethra in children. Apropos of an unusual case of rhabdomyoma of fetal type]". J Urol (Paris) (in French). 93 (1): 43–6. PMID 3031168.
  92. Pinho MM, de Carvalho E Castro J, Ramos RG (October 2013). "Adult rhabdomyoma of the larynx". Int Arch Otorhinolaryngol. 17 (4): 415–8. doi:10.1055/s-0033-1351671. PMC 4399195. PMID 25992049. Vancouver style error: missing comma (help)
  93. Norawat R, Sarkar D, Maybauer MO (2018). "Perioperative management of critical right ventricular inflow obstruction from right atrial rhabdomyoma". Ann Card Anaesth. 21 (4): 430–432. doi:10.4103/aca.ACA_233_17. PMC 6206783. PMID 30333341.